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regulatory T (Treg) cells can be affected by variations in the amount of a cognate antigen (Ag) that is present,
the cell types by which it is expressed and/or presented, and whether Ag recognition occurs in an
inflammatory environment. Recognition of a weakly immunostimulatory self-peptide was able to promote
both thymic CD4+Foxp3+ Treg cell development and the formation of CD4+Foxp3+ Treg cells from
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acquire a T-bet+CXCR3+ phenotype, and to suppress the accumulation of CD4+Foxp3- and CD8+ effector
T cells in the lungs of infected mice. Notably, when cognate Ag was expressed at high levels by antigen
presenting cells, Treg cells also underwent substantial proliferation, but little or no differentiation into a T-
bet+CXCR3+ phenotype occurred, and their ability to modulate an anti-viral immune response was impaired.
This failure to promote the formation of T-bet+CXCR3+Foxp3+ Treg cells could be attributed in part to the
presentation of the cognate Ag by B cells, and in part to their initial activation by a highly stimulatory Ag in a
non-inflammatory environment. Interactions with cognate peptide:MHC complex in these contexts
diminished the ability of Treg cells to differentiate upon subsequent exposure to cognate Ag when it was
derived from virus and presented by dendritic cells in the lung-draining mediastinal lymph nodes.
Collectively, these studies show that the mode of presentation of an Ag can critically affect the formation and
activity of Foxp3+ Treg cells in vivo, and that the type of antigen presenting cell and inflammatory
environment encountered during their initial activation can determine their ability to differentiate into novel
effector phenotypes.
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ABSTRACT 
 
VARIATIONS IN ANTIGEN PRESENTATION DEFINE REGULATORY T CELL 
FORMATION AND ACTIVITY IN VIVO 
 
Katherine Ann Weissler 
 
Andrew J. Caton, Ph.D. 
 
 The studies presented in this dissertation examine how the formation, 
differentiation, and activity of Foxp3+ regulatory T (Treg) cells can be affected by 
variations in the amount of a cognate antigen (Ag) that is present, the cell types by which 
it is expressed and/or presented, and whether Ag recognition occurs in an inflammatory 
environment.  Recognition of a weakly immunostimulatory self-peptide was able to 
promote both thymic CD4+Foxp3+ Treg cell development and the formation of 
CD4+Foxp3+ Treg cells from CD4+Foxp3- T cell precursors in the periphery.  Despite 
promoting Treg cell formation, this weakly immunostimulatory self-Ag was unable to 
induce Treg cell activity during influenza virus infection.  Conversely, when the same Ag 
was derived from an influenza virus, it drove Treg cells to proliferate and acquire a 
T-bet+CXCR3+ phenotype, and to suppress the accumulation of CD4+Foxp3- and CD8+ 
effector T cells in the lungs of infected mice.  Notably, when cognate Ag was expressed 
at high levels by antigen presenting cells, Treg cells also underwent substantial 
proliferation, but little or no differentiation into a T-bet+CXCR3+ phenotype occurred, and 
their ability to modulate an anti-viral immune response was impaired.  This failure to 
promote the formation of T-bet+CXCR3+Foxp3+ Treg cells could be attributed in part to 
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the presentation of the cognate Ag by B cells, and in part to their initial activation by a 
highly stimulatory Ag in a non-inflammatory environment.  Interactions with cognate 
peptide:MHC complex in these contexts diminished the ability of Treg cells to 
differentiate upon subsequent exposure to cognate Ag when it was derived from virus 
and presented by dendritic cells in the lung-draining mediastinal lymph nodes.  
Collectively, these studies show that the mode of presentation of an Ag can critically 
affect the formation and activity of Foxp3+ Treg cells in vivo, and that the type of antigen 
presenting cell and inflammatory environment encountered during their initial activation 
can determine their ability to differentiate into novel effector phenotypes. 
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CHAPTER 1: Introduction and Overview 
 
1.1  Introduction 
 
 Regulatory T (Treg) cells are a subset of CD4+ T cells that are crucial for the 
maintenance of self-tolerance and immune homeostasis in both mice and humans 
(Bennett et al. 2001; Brunkow et al. 2001).  Treg cells are defined by expression of the 
transcription factor Foxp3, which is necessary for their development and persistence, 
and loss of Foxp3 function through either mutation or deletion leads to rapid onset of 
autoimmunity and lymphoproliferative disease in both mice and humans (Brunkow et al. 
2001; Fallarino et al. 2003; Sakaguchi et al. 1995; Williams and Rudensky 2007).  The 
majority of Treg cells also express the IL-2Rα chain CD25, and lymphoproliferative 
disease and autoimmune pathology develops in the absence of CD4+CD25+ T cells 
(Sakaguchi et al. 1995; Willerford et al. 1995).  The majority of Treg cells are believed to 
form in the thymus following recognition of self-Ag (Hsieh et al. 2006), although 
conversion of naïve CD4+Foxp3- cells into Foxp3+ Treg cells in the periphery represents 
an alternative source of these cells (Shevach and Thornton 2014).  In addition to their 
well-established role in the prevention of autoimmunity (Sakaguchi et al. 2006), there is 
increasing evidence that Treg cells also function in other settings in which immune 
activation occurs, such as during the immune response to a pathogen (Bedoya et al. 
2013; Fulton, Meyerholz, Varga 2010; Lund et al. 2008).  Moreover, it has recently 
become apparent that Treg cells must differentiate further and acquire novel 
characteristics in order to effectively regulate immune activation in different contexts 
(Gratz and Campbell 2014).  A greater understanding of how signals transmitted through 
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the T cell receptor (TCR) can determine Treg cell differentiation, activity, and functional 
differentiation will be necessary if Treg cells are to be used in a therapeutic setting.   
 
 
1.2  Regulatory T cell development in the thymus 
 
T cells develop in the thymus, where somatic gene rearrangement in each 
developing thymocyte can lead to the creation of a unique TCR.  This process results in 
the generation of a wide variety of TCR specificities with the potential to recognize a vast 
array of ever-changing pathogen-derived antigens, but also inevitably results in the 
generation of TCRs that recognize self-antigens.  The number of circulating self-reactive 
T cells is limited by the fact that thymocytes must undergo a stringent selection process, 
which results in the positive selection of cells expressing a TCR that weakly recognizes 
self-peptide:MHC complexes, but the deletion of cells bearing a TCR that binds 
self-peptide:MHC complexes too strongly (Palmer 2003).  However, not all thymocytes 
that recognize self-Ag undergo deletion, and an alternative fate for these self-reactive 
thymocytes is differentiation into Foxp3+ Treg cells.   
 
Multiple studies using TCR-transgenic mice in which the TCR is specific for a 
defined self-Ag have established that TCR-mediated recognition of self-Ag can drive 
developing thymocytes to differentiate into Foxp3+ Treg cells.  Our lab has demonstrated 
this concept using TS1 mice, which express a transgenic TCR that recognizes the Site 1 
(S1) epitope of PR8 influenza virus hemagglutinin (HA) presented on I-Ed and that can 
be identified using the monoclonal antibody 6.5 (Kirberg et al. 1994).  In single 
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transgenic TS1 mice, essentially none of the 6.5+CD4SP thymocytes or 6.5+CD4+ T cells 
express Foxp3.  However, when TS1 mice are mated with transgenic mice that express 
the PR8 HA as a neo-self-Ag (termed HA28 mice), the resultant TS1xHA28 mice contain 
significantly more 6.5+CD4SP thymocytes and 6.5+CD4+ T cells that express Foxp3, and 
these 6.5+CD4+Foxp3+ cells are potently suppressive in vitro (Jordan et al. 2001; Larkin, 
Picca, Caton 2007; Lerman et al. 2004; Picca et al. 2009).  Importantly, the development 
of 6.5+ Treg cells in TS1xHA28 mice does not require endogenous rearrangement of the 
TCR, as 6.5+ Treg cells still form in TS1xHA28 mice on a TCRα-/- background and in 
HA28 mice reconstituted with TS1.Rag-/- bone marrow (Jordan et al. 2001; Larkin et al. 
2008).  Thus, TCR recognition of an agonist self-Ag can drive thymocytes to develop into 
Foxp3+ Treg cells.  Other groups using transgenic mice that expressed HA under control 
of an immunoglobulin promoter or an Aire promoter also found that recognition of self 
HA could induce HA-reactive thymocytes to differentiate into Treg cells (Apostolou et al. 
2002; Aschenbrenner et al. 2007).  Furthermore, studies involving TCR transgenic mice, 
in which the TCR is specific for OVA, crossed with mice expressing OVA as a neo-self-
Ag provided evidence that recognition of a different self-Ag can also drive intrathymic 
Treg cell development (Kawahata et al. 2002; Walker et al. 2003).  In the absence of a 
TCR transgene, Treg cells (CD4SPCD25+Foxp3+) and Treg cell progenitors 
(CD4SPCD25+CD122hiFoxp3-) in the thymus express higher levels of Nur77, the 
expression of which reflects TCR signal strength, than do CD4SPCD25-Foxp3- 
thymocytes, indicating that thymocytes that upregulate Foxp3 have received a strong 
TCR signal (Moran et al. 2011).  Furthermore, TCRs derived from Foxp3+ T cells 
directed Treg cell differentiation more effectively than did TCRs derived from Foxp3- T 
cells, providing further evidence that Treg cell differentiation is a TCR instructive process 
(Bautista et al. 2009; Leung, Shen, Lafaille 2009).  Finally, CD4+CD25- T cells 
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transduced with TCRs taken from Treg cells proliferated to a greater extent when 
transferred into WT host mice than did T cells transduced with TCRs acquired from 
CD4+CD25- cells, and T cells expressing a Treg cell-derived TCR caused more rapid 
wasting disease in Rag-/- hosts, further demonstrating their self-reactivity (Hsieh et al. 
2004; Hsieh et al. 2006).  Together, these studies provide evidence that thymically-
derived Treg (tTreg) cells form based on TCR specificity for self-Ag.   
 
Autoreactive thymocytes can differentiate into Foxp3+ Treg cells, but they can 
also undergo deletion, and there is evidence that these processes are inter-related and 
that the abundance of cognate Ag may determine the extent to which each occurs.  In 
many of the studies in which TCR transgenic thymocytes upregulated Foxp3 in the 
presence of cognate Ag, deletion of thymocytes expressing the clonotypic TCR was also 
observed, suggesting that Treg cell differentiation and deletion can occur simultaneously 
and that recognition of the same Ag can drive each process  (Apostolou et al. 2002; 
Aschenbrenner et al. 2007; Kawahata et al. 2002; Larkin et al. 2008; Walker et al. 2003).  
Our lab has previously described studies in which TS1 mice were inter-mated with 
various lineages of HA transgenic mice that express HA at different levels, and the 
amount of 6.5+CD4SP thymocyte deletion that occurred directly correlated with the 
amount of HA mRNA present in the thymus, such that more 6.5+CD4SP deletion was 
observed in mice with higher levels of HA expression (Picca et al. 2009).   Interestingly, 
the percentage of 6.5+CD4SP cells expressing Foxp3 remained similar in all HA 
transgenic mice examined, with the result that 6.5+CD4+Foxp3+ T cells accumulated 
more efficiently in mice with relatively lower levels of HA expression due to the less 
extensive deletion that occurred in these mice relative to mice with higher expression of 
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HA.  Similarly, i.v. injection of HEL and subsequent HEL presentation in the thymus 
could induce both deletion and Foxp3 upregulation in TCR-transgenic thymocytes 
specific for HEL (Atibalentja, Byersdorfer, Unanue 2009).  Injection of higher doses of 
HEL resulted in more extensive deletion of HEL-reactive thymocytes, while the 
percentage that upregulated Foxp3 remained consistent, such that more HEL-specific 
CD4SPFoxp3+ thymocytes accumulated in mice injected with low doses than higher 
doses of HEL (Atibalentja, Byersdorfer, Unanue 2009).  Thus, thymocyte deletion biases 
Treg cell reactivity toward agonist self-peptides present at relatively low abundance.   
 
1.3  Regulatory T cell differentiation from CD4+Foxp3- T cells outside the thymus 
 
 
tTreg cells appear to constitute the majority of the Treg cell population (Hsieh et 
al. 2006; Josefowicz et al. 2012), but in certain circumstances CD4+Foxp3- cells that are 
present in the periphery can differentiate into Foxp3+ Treg cells (termed peripherally-
derived Treg (pTreg) cells) (Yadav, Stephan, Bluestone 2013).    In vitro, exposure to 
TGF-β in conjunction with TCR stimulation induces CD4+CD25- T cells to upregulate 
Foxp3 expression and differentiation into functionally suppressive Treg cells (Chen et al. 
2003; Kretschmer et al. 2005).  In vivo, several studies have suggested that pTreg cells 
may be important in establishing tolerance to foreign antigens that are present at 
mucosal barriers, such as the lungs and intestinal tract.  For instance, a specialized 
subset of CD103+ dendritic cells (DCs) exists in gut associated lymphoid tissues that can 
induce upregulation of Foxp3 in T cells that recognize orally-administered Ag in a TGF-β 
and retinoic acid-dependent manner (Coombes et al. 2007; Sun et al. 2007).  
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Additionally, one study found that multiple TCRs isolated from colonic Treg cells were 
specific Ag derived from commensal bacteria (Lathrop et al. 2011).  Thymocytes that 
were retrovirally-transduced to express TCRs derived from colonic Treg cells did not 
upregulated Foxp3 in the thymus, but mature T cells expressing these TCRs could 
differentiate into pTreg cells and accumulated in the colon, although this only occurred 
when host mice had similar intestinal bacterial composition as the mice from which the 
TCR was originally isolated (Lathrop et al. 2011).  These studies demonstrate that pTreg 
cell formation can occur in gut associated lymphoid tissues based on TCR specificity for 
Ag derived from food or commensal bacteria present in the gut.  Furthermore, mice that 
lack the conserved non-coding sequence-1 (CNS1) element at the Foxp3 locus, which 
display normal tTreg cell formation but impaired Treg differentiation from CD4+Foxp3- T 
cells both in vitro and in vivo following feeding with an Ag, develop gastritis and airway 
inflammation, indicating that the ability of conventional T cells to upregulate Foxp3 after 
encountering a harmless environmental Ag may be crucial to preventing damaging 
inflammation at barrier surfaces (Josefowicz et al. 2012; Zheng et al. 2010).   
 
pTreg cells can also form in non-gut draining LNs in an Ag-dependent manner 
(Apostolou and von Boehmer 2004).  For instance, injection of a fusion protein 
containing the S1 peptide of HA attached to the C terminus of an anti-DEC antibody to 
target HA for endocytosis and presentation by DCs resulted in the upregulation of Foxp3 
and CD25 by adoptively transferred 6.5+CD4+Foxp3- T cells (Kretschmer et al. 2005).  In 
this study, 6.5+ Treg cell differentiation occurred most efficiently when a relatively low 
dose of the anti-DEC-HA fusion protein was used (Kretschmer et al. 2005).  Similarly, a 
higher percentage of moth cytochrome c (MCC)-specific CD4+ T cells upregulated Foxp3 
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when a relatively lower dose of MCC was injected compared with relatively higher doses 
(Gottschalk, Corse, Allison 2010).  Thus, cognate Ag that is injected, rather than present 
at mucosal barriers, can also drive pTreg cell formation in the periphery, and a relatively 
lower dose of Ag favors pTreg cell formation.  However, exogenously administered 
peptides are subject to turn-over and clearance, and how specificity for naturally 
processed self-peptides can direct pTreg cell formation has not been well studied.  
Moreover, naturally processed self-peptides can be expressed at varying levels by 
diverse cell types and at distinct anatomical locations, and how these factors might 
influence pTreg cell formation has not been determined. 
 
1.4  Treg cell stability 
 
 Foxp3 expression is absolutely required for Treg cell formation, however 
retroviral transduction of conventional CD4+Foxp3- T cells with Foxp3 did not result in 
acquisition of the full Treg cell transcriptional signature, indicating that Foxp3 expression 
alone is not sufficient to induce a full, stable Treg cell phenotype (Hill et al. 2007).  
Subsequently, it was discovered that selective demethylation of the CNS2 element 
within the Foxp3 locus occurs in Treg cells but not conventional CD4+ T cells, and is 
required for stable Foxp3 expression (Floess et al. 2007; Polansky et al. 2008).  Treg 
cells isolated directly ex vivo display extensive demethylation at the Foxp3 locus and 
stable expression of Foxp3, but this demethylation was not observed in Treg cells 
formed in vitro in the presence of TGF-β, which can rapidly lose Foxp3 expression upon 
restimulation (Floess et al. 2007; Polansky et al. 2008).  However, when CD4+Foxp3- T 
cells were stimulated with anti-CD3 and TGF-β in the presence of the azacytidine, which 
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inhibits DNA methylation, the CNS2 element was demethylated and stable Foxp3 
expression was induced (Polansky et al. 2008).  Furthermore, Treg cells in which CNS2 
is deleted fail to maintain Foxp3 expression during division (Zheng et al. 2009).  
Together, these studies demonstrate that Foxp3 expression and commitment to the Treg 
cell lineage are unstable in the absence of CNS2 demethylation.  While Treg cells 
constitute a relatively stable lineage under homeostatic conditions (Komatsu et al. 2009; 
Miyao et al. 2012; Rubtsov et al. 2010), there is evidence that they can lose Foxp3 
expression and adopt an effector phenotype under certain inflammatory and 
lymphopenic conditions (Duarte et al. 2009; Laurence et al. 2012; Zhou et al. 2009).  For 
instance, a fraction of CD4+Foxp3+ cells transferred into RAG2-/- mice downregulate 
Foxp3 and acquire the ability to produce cytokines such as IL-2, IFN-γ, and IL-17, and 
this unstable subset was enriched among CD4+Foxp3+ cells that did not express CD25 
(Duarte et al. 2009; Komatsu et al. 2009; Miyao et al. 2012).  Furthermore, a subset of 
CD4+Foxp3+ cells cultured in the presence of IL-6 or IL-27 lost Foxp3 expression and 
gained the ability to produce IL-17, suggesting that cytokine stimulation may also drive 
loss of Foxp3 (Laurence et al. 2012).  These studies indicate that Treg cells may 
downregulate Foxp3 under certain circumstances, but they all used Foxp3GFP reporter 
mice to sort their initial CD4+Foxp3+ T cell population, and concerns were raised that 
contaminating GFP- cells in the sorted population may be the precursors for the 
CD4+Foxp3- T cell population in each experiment (Sawant and Vignali 2014).  Indeed, a 
subsequent study used a Foxp3 lineage tracing mouse strain in which tamoxifen 
treatment resulted in constitutive and heritable expression of YFP in a cohort of cells that 
expressed Foxp3 at the time of treatment, and found that YFP+CD4+ T cells retained 
Foxp3 expression at steady state for up to 5 months and during Th1-type inflammation 
induced by L. monocytogenes infection (Rubtsov et al. 2010).  A separate group using a 
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different Foxp3 lineage tracing mouse model, in which Foxp3 expression resulted in 
constitutive and heritable expression of YFP constitutively rather than inducibly, found 
that transfer of CD4+Foxp3+YFP+ T cells specific for a pancreatic islet autoantigen into 
NOD.TCRα-/- mice resulted in a subset of these cells losing Foxp3 expression and 
initiating IFN-γ production (Zhou et al. 2009).  The same group later showed that a 
population of myelin oligodendrocyte glycoprotein (MOG)-specific YFP+CD4+Foxp3- T 
cells developed in mice during experimental autoimmune encephalomyelitis (EAE), and, 
moreover, that MOG-specific YFP-Foxp3-CD4+ T cells did not upregulated YFP during 
EAE.  These results suggest that these so called “ex-Treg” cells derived from 
CD4+Foxp3+ cells that subsequently lost Foxp3 expression, rather than from transient 
Foxp3 upregulation and subsequent YFP expression in CD4+Foxp3- T cells (Bailey-
Bucktrout et al. 2013).  Furthermore, it was determined that when a population of 
CD4+CD25+Foxp3+ Treg cells displaying full demethylation of CNS2 was transferred into 
mice with developing EAE, a subset of these cells that were specific for MOG, as 
determined by tetramer staining, lost Foxp3 expression (Bailey-Bucktrout et al. 2013).  
Thus, questions remain regarding whether Foxp3 expression is stable in Treg cells and 
the circumstances in which Foxp3 expression may be lost.  
 
1.5  Role of TCR specificity in Treg cell activity in vivo 
 
Treg cells require TCR stimulation to expand and to suppress proliferation of 
effector cells (Cozzo, Larkin, Caton 2003; Takahashi et al. 1998; Thornton and Shevach 
1998), but once activated through the TCR, Treg cells can suppress proliferation of 
CD4+ T cells of other specificities both in vitro and in vivo (Takahashi et al. 1998; Yu et 
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al. 2005).  Treg cells proliferate in vivo following recognition of cognate Ag, both when it 
is present as a self-Ag and when it is provided via immunization, but do not proliferate 
when cognate Ag is absent, and this observation remains true even in the context of 
lymphopenia, which can induce expansion of CD4+Foxp3- T cells (Cozzo, Larkin, Caton 
2003; Walker et al. 2003).  Multiple studies have found that tissue Ag-specific Treg cells 
are enriched in the draining LNs of that tissue.  For instance, OVA-specific DO11 Treg 
cells divide and accumulate preferentially in the pancreatic LN of mice expression OVA 
under control of the rat insulin-promoter (Walker et al. 2003).  Furthermore, Treg cells 
isolated from the ovarian LNs are more effective than Treg cells isolated from non-
draining LNs at suppressing the development of autoimmune ovarian disease in mice 
that were thymectomized at day 3 post-birth (Samy et al. 2005; Samy et al. 2008).  
Similarly, Treg cells capable of suppressing experimental autoimmune prostatitis were 
selectively enriched in the prostate LN, and Treg cells capable of suppressing 
dacryoadenitis were enriched in the lacrimal gland LN (Wheeler, Samy, Tung 2009).  An 
examination of TCR repertoires revealed that Treg cell TCR repertoires vary by 
anatomical location (Lathrop et al. 2008).  Together with the observation that tissue-
specific Ag is selectively presented in draining LNs (Hoglund et al. 1999; Scheinecker et 
al. 2002), these studies provide evidence that tissue-draining LNs are enriched for Treg 
cells that can recognize antigens derived from that tissue, and these Treg cells more 
effectively suppress autoimmune disease in that tissue.  Thus, a role for TCR specificity 
has been established in Treg cell activity as well as in Treg cell formation.   
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1.6  Treg cell activity during infection 
 
 It is becoming increasingly apparent that Treg cells constitute an active 
component of the immune response to a pathogen.  In one of the first published 
experiments to demonstrate the involvement of Treg cells during an infection, 
CD4+CD25+ T cells were shown to accumulate within sites of chronic Leishmania major 
infection in the skin (Belkaid et al. 2002).  Although Foxp3 had not been identified as the 
lineage-defining transcription factor for Treg cells yet, these CD4+CD25+ T cells 
displayed many of the hallmarks of Treg cells, including a high expression level of 
CTLA-4 and low expression of CD45RB, a hypoproliferative phenotype in vitro, and 
strong suppression of CD4+CD25- cell proliferation following anti-CD3 stimulation 
(Belkaid et al. 2002).  Expansion and/or recruitment of Treg cells also occurs in the lungs 
and mediastinal LN during acute respiratory syncytial virus (RSV) infection and in the 
vaginal tract following infection with herpes simplex virus (HSV) 2, suggesting that this 
may be a common occurrence during the response to any pathogen (Fulton, Meyerholz, 
Varga 2010; Lee et al. 2010; Lund et al. 2008).  The Treg cells found at the site of 
infection (the lungs in RSV infection and the vaginal tract in HSV-2 infection) are not only 
present but appear to be dynamically responding, as they express activation markers 
and proliferate to a greater extent than Treg cells in naïve mice (Fulton, Meyerholz, 
Varga 2010; Lee et al. 2010; Lund et al. 2008; Scott-Browne et al. 2007).  The source of 
the Treg cells that accumulate at infection sites has been a matter of considerable 
interest.  One possibility is that CD4+Foxp3- T cells that recognize pathogen-derived Ag 
may convert into CD4+Foxp3+ pTreg cells during an infection.  However, when polyclonal 
populations of Treg cells and non-Treg cells were transferred into mice infected with 
either L. major or M. tuberculosis, the Treg cells isolated from infection sites had 
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expanded from the population of transferred Treg cell, and had not converted from the 
conventional T cells (Belkaid et al. 2002; Shafiani et al. 2010).  Furthermore, when TCR-
transgenic CD4+Foxp3- T cells specific for either M. tuberculosis or influenza virus Ag 
were tracked during infection with each respective pathogen, no upregulation of Foxp3 
occurred, but TCR-transgenic Treg cells expanded during infection when they were 
capable of recognizing the pathogen (Bedoya et al. 2013; Shafiani et al. 2010).  Thus, 
the preponderance of evidence suggests that the Treg cells present at sites of infection 
expand from Treg cell that exist in the pre-immune repertoire and do not differentiate 
from CD4+Foxp3- T cells.  
 
There is evidence that the Treg cells that accumulate at infection sites can 
modulate the anti-pathogen immune response.  Depletion of Treg cells using the anti-
CD25 antibody PC-61 prior to infection resulted in increased virus-specific CD8+ T cell 
proliferation and activation following foot pad injection of HSV-1 virus, and increased the 
number of effector immune cells in the lungs during influenza and RSV infection (Bedoya 
et al. 2013; Fulton, Meyerholz, Varga 2010; Lee et al. 2010; Suvas et al. 2003).  
Furthermore, depletion of Treg cells resulted in more efficient clearance of the pathogen 
in several different infection models (Belkaid et al. 2002; Kursar et al. 2007; Scott-
Browne et al. 2007; Suvas et al. 2003), but in some cases also led to increased 
immunopathology (Cervantes-Barragan et al. 2012; Suvas et al. 2004).  These studies 
suggest a role for Treg cells in curbing the effector immune response during an infection, 
thus potentially averting immunopathology but impairing clearance of the pathogen.  
Other groups have alternatively suggested that Treg cells may support the initiation of an 
immune response to a pathogen.  For instance, in one study, depletion of Treg cells by 
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treatment with diphtheria toxin in Foxp3DTR mice, which express the human diphtheria 
toxin receptor under control of a Foxp3 promoter, prior to genital infection with HSV-2 led 
to increased viral titers in the vaginal tract and spinal cord and exacerbated disease 
(Lund et al. 2008).  It was further shown that mice depleted of Treg cells had fewer 
adaptive and innate immune cells in the vaginal tract at day 2 post infection, although 
effector cell numbers had recovered by day 4 post infection, suggesting that Treg cells 
may be important in the initial recruitment of effector cell subsets into the infected tissue.  
Similarly, depletion of Tregs with anti-CD25 antibody prior to RSV infection resulted in 
decreased numbers of RSV-specific CD8+ T cells in lungs at day 6 post-infection, but 
increased numbers by day 8 post-infection, again supporting the idea that Tregs may 
help direct the initial effector response (Fulton, Meyerholz, Varga 2010).  However, a 
caveat to the use of a Treg cell depletion strategy to examine the function of Treg cells 
during infection is that it results in systemic immune activation and severe disruption of 
immune homeostasis that can eventually lead to death (Kim, Rasmussen, Rudensky 
2007).  Thus, it is possible that the differences in the anti-pathogen immune response 
that are observed in Treg cell-depleted mice are secondary to disruption of immune 
homeostasis, rather than revealing a direct effect of Treg cells on anti-viral effector cells.  
An alternative strategy for assessing the role of Treg cells in infection has been to 
adoptively transfer TCR-transgenic Treg cells that are specific for pathogen-derived 
antigens, and evaluate how their presence affects the immune response during infection.  
Our lab has shown that adoptive transfer of Treg cells specific for influenza virus results 
in decreased accumulation of CD4+Foxp3- and CD8+ T cells in the lungs of influenza 
virus-infected mice (Bedoya et al. 2013).  Similarly, Treg cells expressing a TCR specific 
for an M. tuberculosis Ag accumulated in the lungs and draining LNs during infection, but 
only when the M. tuberculosis strain used contained their cognate Ag, and delayed the 
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arrival of effector cells in the lungs (Shafiani et al. 2010).  These data show that TCR-
mediated recognition of Ag is crucial for Treg cell activity during infection, and that Treg 
cells that recognize pathogen-derived Ag can modulate the effector response.  However, 
the majority of Treg cells present in the pre-immune repertoire appear to be specific for 
self-Ag (Weissler and Caton 2014).  Accordingly, an additional possibility is that Treg 
cells can be activated based on recognition of a selecting self-Ag that is being presented 
at the site of infection, and the extent to which Treg cell recognition of self might drive 
Treg cells to modulate the immune response to a pathogen has not been investigated.   
 
1.7  Functional specialization of Treg cells 
 
 Recently, it has become apparent that Tregs cells can differentiate further in 
response to different stimuli, and acquire distinct transcriptional profiles that allow them 
to maintain immune homeostasis in different circumstances (Campbell and Koch 2011).  
The use of a Foxp3-driven Cre system to conditionally delete IRF4, a transcription factor 
required for differentiation of the Th2 subpopulation of CD4+ T cells (Lohoff et al. 2002), 
in Foxp3-expressing cells resulted in autoimmune lymphoproliferative disease and an 
increase in the percentage of CD4+ T cells producing Th2-associated cytokines but not 
those associated with a Th1 or Th17 CD4+ T cell response (Zheng et al. 2009).  
Similarly, selective deletion of Stat3, which is associated with the Th17 subpopulation of 
CD4+ effector T cells, in Foxp3+ cells resulted in the development of inflammatory bowel 
disease, and the percentage of CD4+ T cells producing IL-17 was selectively increased 
(Chaudhry et al. 2009).  Finally, deletion of T-bet, a transcription factor required for Th1 
effector CD4+ T cell differentiation (Szabo et al. 2000), in Treg cells resulted in failure to 
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control Th1-mediated autoimmune lymphoproliferation (Koch et al. 2009).  Studies from 
our lab have shown that Treg cells that recognize influenza virus Ag differentiate to 
acquire expression of T-bet, CXCR3, Blimp1, and IL-10 during influenza virus infection 
(Bedoya et al. 2013).  Additional work has shown that signaling through the IFN-γR can 
induce T-bet expression in Treg cells, and T-bet can in turn drive CXCR3 expression, 
which suggests that costimulation with viral Ag and IFN-γ during influenza virus infection 
likely prompts Treg cell differentiation in this context (Koch et al. 2009).  However, 
questions remain regarding how variations in Ag presentation and the cytokine 
environment might affect Treg cell differentiation towards a T-bet+ subpopulation. 
 
1.8  Manipulation of Treg cells for therapeutic use 
 
 Expansion or adoptive transfer of Treg cells has been suggested as a potential 
therapy in a variety of settings, including solid organ or hematopoietic stem cell 
transplantation, autoimmune diseases, and allergy (Allan et al. 2008).  In patients with 
autoimmune diseases, such as type 1 diabetes, multiple sclerosis, and rheumatoid 
arthritis, Treg cells that are present are unable to suppress autoimmune disease 
development and show evidence of dysfunction (Ehrenstein et al. 2004; Lindley et al. 
2005; Venken et al. 2008; Viglietta et al. 2004).  It is possible that these Treg cells have 
failed to differentiate appropriately to acquire the necessary capabilities, or that they do 
not have the correct specificity.  Furthermore, adoptive transfer of Treg cells limited 
disease development in mouse models of all three diseases, suggesting that they may 
be an effective treatment in human patients, as well (Morgan et al. 2005; Tang et al. 
2004; Yu et al. 2005).  In one study, umbilical cord blood-derived Treg cells were 
	   16	  
expanded and transferred to patients receiving a hematopoietic stem cell graft, and the 
treatment was well accepted and showed promising results with respect to decreasing 
the incidence of acute graft-versus-host disease (Brunstein et al. 2011).  Additional 
studies have further proven the safety and feasibility of Treg cell adoptive transfer in 
solid organ transplant, although efficacy has not been established (Ferrer et al. 2014).  A 
protocol has recently been established for expanding human alloantigen-reactive Treg 
cells in vitro using good manufacturing practice-compliant reagents, supporting the 
feasibility of Treg cell expansion for adoptive immunotherapy (Putnam et al. 2013).  As 
clinical trials move forward, a better understanding of how variations in Ag presentation 
can affect Treg cell activation and differentiation may increase our ability to induce Treg 
cells to be effective in different settings.  
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CHAPTER 2: Materials and Methods 
 
2.1  Transgenic mice 
 
TS1 mice express a transgenic TCR that is specific for the S1 determinant 
(SFERFEIFPKE) of influenza virus PR8 hemagglutinin presented in the context of MHCII 
I-Ed and can be identified by the monoclonal antibody 6.5 (Kirberg et al. 1994).  HA28 
and HA12 mice express a truncated form of PR8 HA (the NH2 terminal 237 amino acids) 
under control of the SV40 early promoter-enhancer region (Cerasoli et al. 1995; Picca et 
al. 2009; Shih, Cerasoli, Caton 1997).  HACII mice express a full length PR8 HA 
transgene driven by an MHCII promoter (Jordan et al. 2001; Reed et al. 2003).  
BALB/c.Foxp3eGFP (or C.Cg-Foxp3tm2(EGFP)Tch/J) mice (Haribhai et al. 2007) and 
congenic BALB/c.Ly5.1 mice were acquired from The Jackson Laboratory.  BALB/c mice 
were purchased from Charles River Laboratories.  Mice were inter-mated to produce 
TS1.Foxp3eGFP.Ly5.1 mice and TS1xHA28 Foxp3eGFP.Ly5.1 mice.  All experimental mice 
were female, and in cases where transgenes were expressed, experimental mice were 
heterozygous for the TCR transgene, HA transgene, and Ly5.1 allele, and were 
homozygous for the Foxp3eGFP reporter.  All mice were bred and maintained on a 
BALB/c background, and were housed under specific pathogen-free conditions in the 
Wistar Institute Animal Facility.  Experiments were performed according to protocols 
approved by the Wistar Institutional Animal Care and Use Committee. 
 
2.2  Real time quantitative RT-PCR 
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RNA was isolated from harvested tissue using a Biospec Tissue Tearor and TRIzol 
reagent (Life Technologies), and purified and concentrated using an RNeasy kit 
(Qiagen).  cDNA was synthesized with the High Capacity RNA to cDNA kit (Applied 
Biosystems), and RT-qPCR was performed using TaqMan Gene Expression Master Mix 
(Applied Biosystems) on a 7500 Fast Real-Time PCR system. 
 
2.3  Cell sorting and adoptive transfers 
 
For Treg cell induction experiments, 6.5+CD4+CD25-eGFP- cells were sorted from the 
LNs and spleens of TS1.Foxp3eGFP.Ly5.1 mice.  For Treg cell transfer experiments, 
CD4+eGFP+ cells were isolated from the LNs and spleens of TS1xHA28.Foxp3eGFP.Ly5.1 
mice.  In both cases, 106 cells in 150 µL PBS were adoptively transferred into recipient 
mice via tail vein injection.  FACS was performed using a MoFlow (DakoCytomation) or 
FACSAria (BD Biosciences).   
 
2.4  Cell staining and flow cytometry 
 
Single cell suspensions of pLNs (pooled axillary, brachial, and inguinal), mesenteric LNs, 
spleens, thymii, mediastinal LNs and lungs were stained using the Live/Dead Fixable 
Aqua Dead Cell Stain Kit (Invitrogen), blocked with Fc block (BD Biosciences), then 
stained for surface markers at 4 ˚C for 25 minutes.  For intracellular staining, cells were 
fixed and permeabilized after surface staining using the Foxp3 / Transcription Factor 
Staining Buffer Set (eBioscience) according to manufacturer’s instructions.  Antibodies 
were purchased from eBioscience, BD Biosciences, or Invitrogen.  Data was collected 
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using an LSR II flow cytometer (BD Biosciences) and analyzed on FlowJo software 
(Tree Star). 
 
2.5  CellTrace Violet labeling 
 
Cells were washed twice with PBS, then resuspended in pre-warmed PBS at 3x106 
cells/mL with 3 µM CellTrace Violet (Invitrogen), and incubated at 37 ˚C for 20 minutes, 
after which an equal volume of pre-warmed FBS was added, and cells were incubated 
for an additional 5 minutes.  Cells were washed with PBS prior to adoptive transfer or 
addition to in vitro cultures. 
 
2.6  In vitro suppression assay  
 
In a 96-well U-bottom plate, 100,000 CD4-CD8- BALB/c splenocytes, 50,000 FACS-
isolated CD4+6.5+eGFP- responder cells from TS1.Foxp3 mice, and 1 µM S1 peptide 
were combined in supplemented IMDM plus 10% FBS.  CD8-Ly5.1+6.5+eGFP+Treg cells 
were isolated from TS1xHA28. Foxp3eGFP.Ly5.1 mice or from HA28 recipient mice at day 
7 post-transfer of 6.5+CD4+CD25-eGFP- cells from TS1.Foxp3eGFP.Ly5.1 mice; these 
Treg cells were added to the culture at a 1:2 or 1:4 ratio relative to the responder cells.  
Cells were stained for flow cytometric analysis after 3 days of culture. 
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2.7  Influenza viruses 
 
The influenza viruses PR8 (A/Puerto Rico/8/1934 [H1N1]) and its derivative RV6, which 
contains a single amino acid substitution in the Site 1 peptide of PR8 HA 
(SFERFEIFPKE mutated to SFERFKIFPKE), were propagated in 10-d hen’s 
embryonated eggs (Hurwitz et al. 1984).   
 
2.8  Influenza virus infection 
 
Mice were anesthetized by i.p. injection of ketamine/xylazine (70/7 mg/kg), and 0.003 
HAU of PR8 virus or 0.005 HAU of RV6 virus or 0.017 HAU of J1 virus was administered 
intranasally in 50 µL PBS. 
 
2.9  ELISA for IFN-γ 
 
Blood was collected immediately post-mortem by cardiac puncture, allowed to clot, then 
spun down to separate out serum.  To perform the ELISA, a 96-well plate was coated 
with anti-IFN-γ antibody (clone R4-6A2; BD Biosciences) overnight.  Serum was plated 
undiluted and diluted 1:3 with PBS supplemented with 10%FBS.  Biotinylated-anti-IFN-γ 
(clone XMG1.2; eBioscience) was used as the secondary antibody, and streptavidin-
HRP and tetramethylbenzidine (eBioscience) were used to detect bound antibody, and 
the concentration was calculated based on a standard curve using an IFN-γ standard. 
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2.10  In vitro APC : T cell coculture 
 
B cells (B220+CD11c-CD11b-), DCs (B220-CD11c+Ly6C-Ly6G-), neutrophils (B220-
CD11c-CD11b+Ly6GhiLy6Clo) and inflammatory monocytes (B220-CD11c-CD11b+Ly6G-
Ly6Chi) were isolated from the mediastinal LNs of mice at day 5 post-infection.  These 
APCs were plated in a 96 well U-bottom plate either undiluted, or diluted into CD4-CD8- 
feeder cells from the spleen of a BALB/c mouse, such that 100,000 cells were present in 
each well in supplemented IMDM plus 10% FBS.  60,000 cells isolated from the LNs of a 
TS1xHA28.Foxp3eGFP mouse and labeled with CellTrace Violet were then added to each 
well.  Division and CXCR3 expression by the Treg cells from the TS1xHA28.Foxp3eGFP 
were determined after 4 days of culture at 37 ˚C.   
 
2.11  Statistical analyses 
 
Statistical tests were performed with GraphPad Prism software.  A one-way ANOVA 
followed by Tukey’s post-test was used for comparisons between groups within the 
same dataset.  A two-tailed Student t test was used where indicated when comparing 
two independent groups.  Mean +SEM represented in all bar graphs. *p<0.05; **p<0.01; 
***p<0.005. 
 
2.12  Solutions 
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Phosphate buffered saline (PBS): 2.2mM NAH2PO4 [Anhydrous], 12.6 mM Na2HPO4 
[Anhydrous], 6.2 mM KCl, and 170 mM NaCl (solution pH 7.4) 
 
FACS buffer: PBS, 2% heat-inactivated fetal bovine serum (FBS; Tissue Culture 
Biologicals, Tulare, CA) 
 
Supplemented Iscove’s Modified Dulbecco’s Medium (IMDM; Mediatech, Inc., Herndon, 
VA), 10% FBS, 5x10-5 M 2-mercaptoethanol, and 100 µL/mL gentamycin 
 
RBC lysis buffer: 0.15 M NH4CL and 0.01 M Tris (pH 7.5)  
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CHAPTER 3:  Distinct modes of Ag presentation promote Treg cell formation in 
vivo 
 
3.1  Introduction 
 
 During T cell development within the thymus, a signal through the TCR is 
required for positive selection and survival of a thymocyte, and thymocytes that fail to 
interact with MHC molecules are deleted from the repertoire (Klein et al. 2014).   
However, thymocytes that receive too strong a TCR signal from recognition of self-
peptide:MHC complexes are deleted, or alternatively, differentiate into Foxp3+ Treg cells 
(Klein et al. 2014).  Although the precise mechanism that determines whether 
autoreactive thymocytes undergo deletion or become Treg cells remains undetermined, 
there is evidence that the abundance of the cognate self-Ag can play a role in fate 
determination, with Treg cell formation biased towards thymocytes that recognize a less 
prevalent cognate self-Ag (Jordan et al. 2001; Picca et al. 2009).  The clonal frequency 
of thymocytes expressing a particular TCR can also affect the extent of Treg cell 
formation in the thymus, with less thymocytes upregulating Foxp3 when a higher 
percentage of thymocytes express a transgenic TCR (Bautista et al. 2009; Leung, Shen, 
Lafaille 2009).  Perhaps due in part to the existence of this niche that limits the number 
of Treg cells of a given specificity that can develop, some autoreactive thymocytes are 
able to leave the thymus and enter the periphery, as evidenced by the sudden 
autoimmune lymphoproliferative disease that develops when Treg cells are eliminated 
(Kim, Rasmussen, Rudensky 2007).  Whether these autoreactive T cells can later 
upregulate Foxp3, or if they are intrinsically incapable of doing so, perhaps due to 
changes in the epigenome, has not been explored.   
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 Mature CD4+ T cells that are signaled through the TCR complex upon recognition 
of cognate Ag:MHCII complex can proliferate and adopt distinct effector cell fates (i.e. 
Th1, Th2, Th17, pTreg, or follicular helper T cells), or alternatively they can undergo 
deletion or become anergic (Vahedi et al. 2013).  Exposure of CD4+ T cells to Mls 
superantigens in vivo resulted in expansion, then deletion, of Mls reactive T cells 
(McCormack et al. 1993; Webb, Morris, Sprent 1990).  Furthermore, when CD4+ T cells 
specific for HA were adoptively transferred into mice expressing HA as a self-Ag, cells 
were rapidly deleted and the remainder became anergic, in that they failed to proliferate 
or produce IFN-γ upon subsequent stimulation (Lanoue et al. 1997).  Similarly, CD4+ T 
cells isolated from a mouse that had been tolerized against human γ-globulin (HGG) by 
i.p. injection of HGG failed to proliferate or produce IL-2 or IL-4 upon subsequent 
stimulation with HGG (Chu et al. 1995).  Anergy and deletion constitute two potential 
mechanisms of establishing peripheral tolerance, but tolerance can also be achieved by 
conversion of CD4+Foxp3- T cells into Foxp3+ Treg cells.  While thymically-derived Treg 
(tTreg) cells appear to constitute the majority of the Treg cell population (Hsieh et al. 
2006; Josefowicz et al. 2012), these tTreg cells are insufficient for maintaining immune 
homeostasis (Josefowicz et al. 2012), and the Treg cell repertoire is supplemented by 
the conversion of CD4+Foxp3- T cells into CD4+Foxp3+ Treg cells in the periphery 
(Yadav, Stephan, Bluestone 2013).  CD4+Foxp3- conventional T cells that express a 
TCR specific for Ag derived from colonic microbiota or from food, neither of which would 
be present in the thymus during T cell development, can upregulate Foxp3 and become 
functional Treg cells (Lathrop et al. 2011; Sun et al. 2007).  A specialized subset of 
CD103+ DCs that exists within the gut draining LNs facilitates this Treg cell differentiation 
in a TGF-β and retinoic acid dependent manner (Coombes et al. 2007; Sun et al. 2007).  
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However, CD4+Foxp3- T cells can also convert into Foxp3+ Treg cells in the pLNs 
following injection of cognate Ag, and in some cases, low doses of the peptide were 
found to favor Foxp3+ pTreg cell formation (Apostolou and von Boehmer 2004; 
Gottschalk, Corse, Allison 2010; Kretschmer et al. 2005).  It has furthermore been 
shown that recognition of self-Ag can drive CD4+Foxp3- cells to upregulate Foxp3 in 
lymphopenic mice (Knoechel et al. 2005).  The extent to which recognition of self-Ag can 
induce pTreg cell differentiation in lymphoreplete mice, and how variations in 
presentation of a self-Ag might affect this process, have not been well studied. 
 
 The transcription factor Helios is expressed in nearly all CD4SPFoxp3+ cells in the 
thymus and marks thymocytes that have received a strong signal through the TCR, but 
Helios is not present in Treg cells formed in vitro by TCR stimulation of CD4+Foxp3- T 
cells in the presence of TGF-β, or in pTreg cells that differentiate after mice are fed 
cognate Ag (Daley, Hu, Goodnow 2013; Gottschalk, Corse, Allison 2012; Hadis et al. 
2011; Thornton et al. 2010).  Due to these observations, Helios was originally identified 
as a marker of tTreg cells, however subsequent studies revealed that CD4+Foxp3- T 
cells that upregulated Foxp3 upon recognition of an injected Ag additionally upregulated 
Helios (Gottschalk, Corse, Allison 2012).  The discrepancy in these observations has not 
been satisfactorily resolved, and why Helios may be upregulated in pTreg cells in some 
circumstances but not in others remains unclear. 
 
In this section, we describe studies investigating how varying the presentation of 
a self-Ag can affect the fate of autoreactive thymocytes and T cells.  We made use of 
several different transgenic mouse lineages that express HA as a self-Ag at different 
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levels and in different cell types, and assessed the fate of TCR-transgenic thymocytes 
and T cells specific for HA in these various environments.  A low dose of a self-Ag 
favored Treg cell formation in the thymus, while a higher dose resulted in increased 
deletion of reactive thymocytes.  In the periphery, a relatively less immunostimulatory 
form of self-Ag induced a subset of reactive CD4+Foxp3- T cells to upregulate Foxp3 and 
differentiated into Helios+ Treg cells, but the same self-Ag expressed at higher levels on 
APCs and presented in a more immunostimulatory manner induced reactive CD4+Foxp3- 
T cell proliferation but not Foxp3 expression.  We have additionally assessed whether 
previous exposure to cognate Ag during development, or the presence of tTreg cells of 
the same specificity can affect the conversion of CD4+Foxp3- cells into pTreg cells.  
Collectively, these studies reveal that the mode of presentation of a self-Ag plays a 
determining role in the fate of thymocytes and T cells that recognize that Ag.  
 
3.2  Results 
 
3.2.1  The HA transgene is expressed at lower levels and self-HA is presented with 
less stimulatory potency in HA28 mice relative to HACII mice 
 
HA28 mice and HACII mice are previously described transgenic lineages that 
express the hemagglutinin molecule from the influenza virus A/PR/8/34 (PR8) as a neo-
self Ag (Jordan et al. 2001; Reed et al. 2003; Shih, Cerasoli, Caton 1997).  HA28 mice 
express a truncated form of PR8 HA (the NH2-terminal 237 amino acids) driven by the 
SV40 early promoter-enhancer region (Cerasoli et al. 1995), while HACII mice express 
the full length PR8 HA under control of an MHC Class II I-Eα promoter (Reed et al. 
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2003).  The different insertion sites and promoters for the HA transgene in the two 
lineages cause the HA to be expressed by different cell types and ultimately in 
drastically different amounts.  Analysis by RT-PCR showed that the amount of HA RNA 
was increased in both lineages over background (BALB/c control) in the thymus, spleen, 
pLNs, and intestines (Fig. 3-1 A).  However, over 1000-fold more HA RNA was found in 
HACII mice relative to HA28 mice in all tissues examined (Fig. 3-1 A).  Adoptive transfer 
of CellTrace-labeled, HA-specific CD4+ T cells from TS1 mice (transgenic mice 
expressing an HA-specific TCR recognized by the anti-clonotypic mAb 6.5 (Kirberg et al. 
1994)) demonstrated that the endogenous HA could induce T cell division in both 
lineages (Fig. 3-1 B).  In contrast, no division occurred in BALB/c mice, in which HA is 
not present.  Furthermore, a higher percentage of T cells underwent more rounds of 
division in HACII mice compared with HA28 mice.  Thus, higher levels of HA mRNA and 
targeted expression to MHC Class II+ cells makes the neo-self HA a more potent 
stimulator of CD4+ T cells in HACII mice than in HA28 mice. 
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3.2.2  Stimulatory potency of the HA self-Ag determines the extent of autoreactive 
thymocyte deletion and Treg cell formation 
 
To evaluate how the differences in HA expression in HA28 versus HACII mice 
might influence autoreactive thymocyte development, we mated both lineages with TS1 
mice to produce TS1xHA28 and TS1xHACII mice.  In TS1xHA28 mice, there was a 
significant decrease in the number of 6.5+CD4SP thymocytes relative to TS1 mice, but 
the number of 6.5+CD4SPFoxp3+ thymocytes was significantly increased (Fig. 3-2 A).  
This result is consistent with previous studies showing that the self HA peptide can 
induce both 6.5+CD4SP thymocyte deletion and 6.5+CD4SPFoxp3+ thymocyte formation in 
TS1xHA28 mice through processes driven predominantly by HA expression on 
radioresistant cell types (Jordan et al. 2001; Lerman et al. 2004).  In TS1xHACII mice, 
the number of 6.5+CD4SP cells was further reduced relative to either TS1 or TS1xHA28 
mice (Fig. 3-2 A).  Although the percentage of 6.5+CD4SP thymocytes that were Foxp3+ 
was increased compared with TS1 mice, the severe deletion of 6.5+CD4SP thymocytes 
led to there being no significant change in the number of 6.5+CD4SPFoxp3+ thymocytes 
(Fig. 3-2 A).   
 
The relative representations of 6.5+CD4+ T cells in the peripheral LNs of TS1, 
TS1xHA28 and TS1xHACII mice mostly paralleled those of 6.5+CD4SP thymocytes (Fig. 
3-2 B).  However, in contrast to what we observed in the thymus, 6.5+CD4+ T cells were 
no less abundant in the peripheral LNs of TS1xHA28 mice than TS1 mice, suggesting 
that homeostatic expansion of both 6.5+CD4+Foxp3- and 6.5+CD4+Foxp3+ cells occurred 
in the periphery.   
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Collectively, these studies show that differences in the amounts and/or cell types 
in which the HA self peptide is expressed affect the extent to which it induces both 
deletion of HA-specific thymocytes and their differentiation into Foxp3+ Treg cells.  
Moreover, the HA self-Ag promotes formation of significantly higher numbers of 
6.5+CD4+Foxp3+ Treg cells in TS1xHA28 mice than in TS1xHACII mice, in part because 
less deletion occurs in the less immunostimulatory setting. 
 
3.2.3  Autoreactive CD4SP thymocytes upregulate CD25 and Helios 
 
 We additionally assessed the expression of CD25 and Helios on 6.5+CD4SP 
thymocytes in TS1xHA28 mice to determine how their expression correlated with 
exposure to cognate self-Ag and Foxp3 expression (Fig. 3-3).  CD25 is part of the IL-2 
receptor, and exposure to IL-2 represents a crucial second step (following TCR 
engagement) in thymic Treg cell development (Lio and Hsieh 2008).  Helios upregulation 
in thymocytes can occur following a strong TCR signal, while outside the thymus, Helios 
is predominantly expressed in Foxp3+ Treg cells (Daley, Hu, Goodnow 2013; Thornton 
et al. 2010).  In the thymus of a TS1xHA28 mouse, CD25 was upregulated in 
approximately 60% of 6.5+CD4SPFoxp3+ cells and 20% of 6.5+CD4SPFoxp3- cells (Fig. 3-
3 A).  Helios was present in nearly 100% of 6.5+CD4SPFoxp3+ thymocytes and 70% of 
6.5+CD4SPFoxp3- thymocytes.  Neither molecule was expressed by 6.5+CD4SP 
thymocytes in TS1 mice, in which cognate Ag is not present.   
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Thus, expression of both molecules is driven by recognition of self-Ag, but is not 
dependent on Foxp3 expression.  In the pLNs, 6.5+CD4+ cells in a TS1xHA28 mouse 
expressed neither CD25 nor Helios, indicating that these molecules either were lost or 
that 6.5+CD4SP thymocytes on which they were expressed were either deleted or 
differentiated into Treg cells (Fig. 3-3 B).  A higher percentage of 6.5+CD4SPFoxp3+ cells 
expressed CD25 in the pLNs compared with the thymus, while the percentage 
expressing Helios was lower in the pLNs.  To determine how expression of CD25 and 
Helios in TS1xHA28 mice corresponded to that in mice with unmanipulated TCR 
repertoires, we assessed their expression in a BALB/c mouse.  In the thymus, 
approximately 80% of CD4SPFoxp3+ cells expressed CD25, and again this percentage 
was increased in the pLNs (Fig. 3-3 B).  Very little CD25 expression was seen in 
CD4SPFoxp3- thymocytes or T cells.  Similar to the 6.5+CD4SPFoxp3+ thymocytes in a 
TS1xHA28 mouse, almost all CD4SPFoxp3+ thymocytes in a BALB/c mouse expressed 
Helios, and the percentage of Helios+ cells decreased in the pLN.  A small subset of 
CD4SPFoxp3- BALB/c thymocytes expressed Helios, but mature Foxp3- T cells in the 
periphery did not.  These data show that upregulation of Helios marks autoreactive 
CD4SP thymocytes, as 6.5+CD4SP thymocytes express Helios in TS1xHA28 mice, but not 
in TS1 mice in which they are not exposed to cognate Ag.  Moreover, Helios is present 
in both 6.5+CD4SPFoxp3- and 6.5+CD4SPFoxp3+ cells, and similar populations of 
Helios+CD4SPFoxp3+ and Helios+CD4SPFoxp3- thymocytes were found in BALB/c mice, 
suggesting that Ag-experienced CD4SPFoxp3+ and CD4SPFoxp3- cells are present in the 
thymus of unmanipulated BALB/c mice. 
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3.2.4  Foxp3 upregulation by CD4+CD25-Foxp3- cells occurs following recognition 
of a self-Ag in cells that have undergone limited rounds of division  
 
To investigate whether recognition of self-Ag could induce CD4+CD25-Foxp3- 
cells to differentiate into Foxp3+ Treg cells after they had left the thymus, we purified 
congenically-marked 6.5+CD4+CD25-eGFP-Ly5.1+ cells from the LNs of 
TS1.Foxp3eGFP.Ly5.1 mice (the Foxp3eGFP reporter allele was used to purify Foxp3- cells 
based on the absence of eGFP expression), labeled the cells with CellTrace Violet, and 
transferred them into BALB/c, HA28, or HACII hosts (Fig. 3-4 A).  eGFP expression in 
the Foxp3eGFP reporter mouse was previously described to accurately reflect Foxp3 
expression in CD4+ T cells (Haribhai et al. 2007), and intracellular staining with anti-
Foxp3 antibody revealed that Foxp3 and eGFP were consistently expressed in the same 
cells (Fig. 3-4 B).  Three days after transfer we examined the extent of division and 
eGFP upregulation (as an indication of Foxp3 expression) of 6.5+CD4+ cells in pooled 
non-gut associated (brachial, axillary and inguinal) peripheral LNs (pLNs).  The 6.5+CD4+ 
T cells in the pLNs of BALB/c mice remained undivided and 99% did not express Foxp3, 
providing an internal control demonstrating the purity of the sort (Fig. 3-3 C).  In contrast, 
many of the 6.5+CD4+ cells isolated from the pLNs of HA28 mice had undergone several 
rounds of division, and a significantly higher percentage of these cells expressed Foxp3 
compared to those isolated from BALB/c mice (Fig. 3-3 C).  Moreover, the 6.5+CD4+ 
cells that had upregulated Foxp3 in HA28 mice were almost exclusively among those 
that remained undivided or had undergone one or two divisions, while many of those that 
remained Foxp3- had undergone 3-5 rounds of division (Fig. 3-3 D).   
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Interestingly, when naturally-occurring 6.5+Foxp3+ Treg cells from TS1xHA28 
mice were transferred into HA28 mice, they also underwent much less division in 3 days 
than did 6.5+Foxp3- cells isolated from TS1 mice, suggesting that a relatively 
hypoproliferative response may be an intrinsic part of the Treg cell identity (Fig. 3-3 E).  
In HACII recipients, all of the 6.5+CD4+CD25-eGFP-Ly5.1+ T cells had undergone 
multiple rounds of division, and the percentage that had upregulated Foxp3 expression 
was no higher than in BALB/c mice (Fig. 3-3 C).  Thus, recognition of self can drive 
pTreg cell differentiation, and autoreactive T cells that upregulated Foxp3 had 
undergone limited rounds of division.   
 
3.2.5  The extent of 6.5+CD4+Foxp3- T cell conversion to Foxp3+ Treg cells depends 
on the stimulatory potency of the self-Ag 
 
Previous studies have variously shown that mature CD4+ T cells are capable of 
undergoing expansion, deletion and/or conversion into Foxp3+ Treg cells upon antigenic 
stimulation in the periphery.  To assess how differences in the expression of self-HA in 
HA28 and HACII mice might influence these different fates, we again purified 
congenically-marked 6.5+CD4+CD25-eGFP-Ly5.1+ cells from the LNs of 
TS1.Foxp3eGFP.Ly5.1 mice, and transferred them into BALB/c, HA28, or HACII hosts 
(Fig. 3-5 A).  We then assessed the accumulation and Foxp3 expression of 
Ly5.1+CD4+cells at later time points.  When we initially analyzed HA28 and HACII mice 
at 14 and 21 days post-transfer, we found that recoveries were variable and that some 
mice contained no Ly5.1+CD4+cells, while there were good recoveries from other 
individual mice (Fig. 3-5 B,C).  One explanation for this irreproducibility could be that the 
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Ly5.1+ cells were being rejected because expression of GFP by CD4+ T cells was in 
some individuals promoting formation of GFP-specific CD8+ T cells that were rejecting 
the transferred cells.  Accordingly, we repeated the day 14 and day 21 transfers of 
Ly5.1+6.5+CD4+Foxp3- cells into BALB/c.Foxp3eGFP, HA28.Foxp3eGFP, and 
HACII.Foxp3eGFP mice, and in this setting we obtained consistent and equivalent 
recoveries of Ly5.1+CD4+ cells from all of the individual mice within a group (Fig. 3-6 A).   
 
 In HA28 mice, similar numbers of Ly5.1+CD4+Foxp3+ T cells were recovered at 
day 7 after transfer as had been obtained 3 days after transfer (Fig. 3-6 B).  By contrast, 
approximately 3 times as many Ly5.1+CD4+ T cells were recovered in HACII mice at 7 
days post transfer than after 3 days, but there was again negligible accumulation of 
Ly5.1+CD4+Foxp3+ T cells. In HA28.Foxp3eGFP mice, the number of Ly5.1+CD4+ T cells 
that were recovered 21 days after transfer was no higher than in BALB/c mice, but 
nearly half of these cells expressed Foxp3 (which was undetectable in Ly5.1+CD4+ T 
cells recovered from BALB/c mice) (Fig. 3-6 B).  By contrast, sizable populations of 
Ly5.1+CD4+ T cells were recovered 21 days after transfer into HACII.Foxp3eGFP mice, but 
there again was little or no expression of Foxp3 by these cells.  Thus, expression of HA 
as a self-Ag with a low stimulatory potency drives the differentiation and accumulation of 
CD4+Foxp3+ T cells from CD4+Foxp3- precursors outside of the thymus more efficiently 
than expression of HA in a more immunostimulatory manner.   
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3.2.6  6.5+ pTreg cells formed in HA28 mice suppress 6.5+CD4+ T cell proliferation 
in vitro 
  
To determine the stability and suppressive capacity of the CD4+Foxp3+ T cells 
that were formed in HA28 mice, we isolated 6.5+eGFP+Ly5.1+ cells from the pLNs of 
HA28 mice at day 7 post-transfer of CD4+6.5+CD25-eGFP-Ly5.1+ cells from 
TS1.Foxp3eGFPLy5.1 mice.  These purified cells were then incubated for 3 days in vitro 
with S1 peptide and Ag presenting cells, and their expression of Foxp3 and ability to 
suppress proliferation of co-cultured Ly5.1-6.5+Foxp3eGFP- responder CD4+ T cells from 
TS1.Foxp3eGFP mice were assessed (Fig. 3-6 C).  In parallel cultures, we included 
thymically-derived tTreg cells (i.e. 6.5+CD4+eGFP+Ly5.1+ Treg cells from 
TS1xHA28.Foxp3eGFP mice) in place of the pTreg cells in order to compare stability and 
suppressive ability between pTreg cells and tTreg cells of the same specificity.  While 
nearly 100% of tTreg cells had maintained Foxp3 expression in culture, a higher 
percentage of Ly5.1+CD4+ pTreg cells formed in HA28 mice cells appeared to have lost 
Foxp3 expression (Fig. 3-6 C).  Nevertheless, more than 70% of the Ly5.1+CD4+ pTreg 
cells maintained eGFP expression, and were as effective as tTreg cells in suppressing 
the proliferation of Ly5.1-CD4+ responder T cells.  These data show that pTreg cells 
formed in HA28 mice had similar suppressive ability in vitro as tTreg cells of the same 
TCR specificity, but exhibited less stable expression of Foxp3. 
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3.2.7  6.5+CD4+ T cells that upregulate Foxp3 in HA28 mice lose the ability to 
produce IL-2 and IFN-γ  
 
To determine the ability of autoreactive CD4+Foxp3- T cells to produce cytokines, 
we isolated cells from the pLNs of BALB/c.Foxp3eGFP, HA28.Foxp3eGFP, and 
HACII.Foxp3eGFP mice that had received 6.5+CD4+CD25-eGFP-Ly5.1+ cells from the LNs 
of TS1.Foxp3eGFP.Ly5.1 mice 14 days previously, stimulated them in vitro with PMA and 
ionomycin, and performed an intracellular cytokine stain.  We found that Ly5.1+CD4+ 
cells re-isolated from BALB/c.Foxp3eGFP mice were capable of producing little or no IL-2 
and IFN-γ (Fig. 3-7).  When Ly5.1+CD4+ cells were re-isolated from HA28.Foxp3eGFP 
mice, the Foxp3- subset were capable both IL-2 and IFN-γ.  In contrast, 
Ly5.1+CD4+Foxp3+ pTreg cells isolated from HA28.Foxp3eGFP mice showed little or no 
evidence of cytokine production, consistent with a reported role for Foxp3 in inhibiting 
IL-2 and IFN-γ production (Bettelli, Dastrange, Oukka 2005; Hori, Nomura, Sakaguchi 
2003).  Interestingly, despite proliferating more heavily in HACII mice, the 
Ly5.1+CD4+Foxp3- cells isolated from this environment were less capable of IFN-γ and 
IL-2 production than when they were isolated from an HA28 mouse (Fig. 3-7).  We 
additionally saw little evidence of IL-17 production by these cells (data not shown).  
6.5+CD4+Foxp3- cells adoptively transferred into HACII mice may adopt a different 
effector fate, or alternatively, decreased cytokine production has been observed during 
CD4+ T cell anergy and exhaustion, and the ultimate fate of these cells was not 
explored.   
 
	   42	  
 
 
  
	   43	  
3.2.8  pTreg cells formed in pLNs of HA28 mice gradually acquire a Helioshigh and 
CD25high phenotype 
 
To further characterize the Foxp3+CD4+ T cells that were being formed in 
response to the HA self-Ag in HA28 mice, we examined expression of the transcription 
factor Helios and the IL-2Rα chain CD25.  Expression of both molecules increased 
progressively in the population of Ly5.1+CD4+Foxp3+ pTreg cells isolated from HA28 
mice (Fig. 3-8).  This observation could be explained by either the selective persistence 
of cells with high expression of Helios and CD25, or by their gradual upregulation within 
all cells that acquired Foxp3.   Notably, the Ly5.1+CD4+ T cells that had not acquired 
Foxp3 expression appeared to transiently upregulate Helios and CD25 relative to cells 
that had been transferred into BALB/c mice at early stages post transfer, but very little 
expression of these molecules could be detected by days 14 and 21 post-transfer (Fig. 
3-8).  These data show that Treg cells that develop in peripheral lymph nodes can 
acquire a Helioshi and CD25hi phenotype that is similar to what we have observed in 
tTreg cells. 
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3.2.9  6.5+ pTreg cells isolated from the mesLNs of HA28 hosts expressed lower 
levels of Helios than 6.5+ pTreg cells isolated from pLNs 
 
Since previous studies have identified Ag-presenting cells in gut mucosal tissue 
that promote Foxp3+ Treg cell formation (Coombes et al. 2007; Sun et al. 2007), we also 
assessed Ly5.1+ cell accumulation and Foxp3 upregulation in the mesenteric LN 
following transfer of 6.5+CD4+CD25-eGFP- cells from TS1.Foxp3eGFP.Ly5.1 mice into 
BALB/c, HA28, or HACII recipients.  For the most part, we found no significant 
differences between the extent of either Ly5.1+CD4+ T cell accumulation or Foxp3 
upregulation in the mesLN relative to non-gut-draining pLNs (Fig. 3-9 A).  The one 
exception was that a significantly higher percentage of donor-derived Ly5.1+ cells had 
upregulated Foxp3 in the mesLNs of HACII mice than BALB/c mice at day 3 post-
transfer (Fig. 3-9 A).   
 
We also examined Helios levels on Ly5.1+CD4+Foxp3+ T cells that had been 
isolated from the mesLNs of HA28 mice (Fig. 3-9 B).  Interestingly, the mesLN contained 
significantly higher percentages of Ly5.1+CD4+Foxp3+ T cells that did not express Helios 
than were found in the non-gut-draining PLN (Fig. 3-9 B).  Since more than 90% of the 
Ly5.1+CD4+Foxp3+ isolated from each site expressed the 6.5 clonotypic TCR, this 
indicates that factors other than TCR specificity must determine the extent of Helios 
upregulation by Foxp3+CD4+ T cells.  These studies suggest that anatomical location 
may be a crucial factor in determining the extent to which Helios upregulation occurs in 
pTreg cells. 
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3.2.10  In HA12 mice, a higher percentage of autoreactive 6.5+CD4+ T cells 
upregulate Foxp3 in the mesLN than in the non-gut-draining LNs   
 
 In addition to adoptively transferring 6.5+CD4+CD25-eGFP- cells from 
TS1.Foxp3eGFP.Ly5.1 mice into BALB/c, HA28, and HACII recipients, we also transferred 
them into HA12 mice.  The HA12 transgenic lineage has been described previously, 
and, like the HA28 mouse, express a truncated form of HA under control of an SV40 
promoter.  Studies involving the use of bone marrow chimeras have shown that the HA 
in HA12 mice is expressed on both radioresistant and bone marrow-derived cells, while 
in HA28 mice, HA is primarily expressed by non-hematopoietic cells (Picca et al. 2009).  
RT-PCR analysis showed an intermediate amount of HA being transcribed in the 
spleens, pLNs, mesLNs and intestines of HA12 mice relative to HA28 and HACII mice 
(Fig. 3-10 A).  Accordingly, 6.5+CD4+ T cells transferred into HA12 mice had undergone, 
on average, more divisions than in an HA28 mouse but less than in an HACII mouse in 
both the pLNs and mesLNs at day 3 post-transfer (Fig. 3-10 B).  The percentage of 
Ly5.1+ cells that upregulated Foxp3 in the pLNs of an HA12 mouse was significantly 
lower than in an HA28 mouse at days 3 and 7 post-transfer, and was again confined to 
cells that have undergone little or no division (Fig. 3-10 C).  In contrast, in the mesLNs, 
the percentage of Ly5.1+ cells expressing Foxp3 was significantly higher in an HA12 
mouse than an HA28 mouse, and the difference in the proliferation history of Foxp3+ 
cells versus Foxp3- cells was less dramatic.  A similar result was obtained when 
transferred cells were re-isolated at day 7 post-transfer (Fig. 3-10 D).  Thus, the fate of 
autoreactive CD4+Foxp3- T cells can vary by location even when cognate Ag is 
expressed systemically. 
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3.2.11  6.5+CD4+CD25-Foxp3- cells isolated from the periphery of TS1xHA28 mice 
can upregulate Foxp3 in HA28 mice 
 
We were curious as to whether 6.5+CD4+Foxp3- T cells in the periphery of 
TS1xHA28 mice were intrinsically incapable of differentiating into Foxp3+ Treg cells, 
given that they had so far failed to do so despite the presence of HA in both the thymus 
and periphery expressed in a manner that was capable of driving 6.5+Foxp3+ Treg cell 
formation.  In order to address this question, we isolated 6.5+CD4+CD25-eGFP-.Ly5.1+ 
cells from the LNs of either TS1.Foxp3eGFP.Ly5.1 mice or TS1xHA28.Foxp3eGFP.Ly5.1, 
labeled them with CellTrace Violet, and transferred them into HA28 mice (Fig. 3-11 A).  
At day 3 post-transfer, cells from both types of donor mice had undergone similar 
numbers of divisions, but a slightly higher percentage of transferred 6.5+CD4+ cells from 
TS1xHA28.Foxp3eGFP.Ly5.1 mice than from TS1.Foxp3eGFP.Ly5.1 had upregulated 
Foxp3 (Fig. 3-11 B).  By contrast, at day 14 post-transfer, similar numbers of Ly5.1+ cells 
from each donor source had accumulated and the percentage of each expressing Foxp3 
was not significantly different (Fig. 3-11 C).  Thus, 6.5+Foxp3- cells that exist in 
TS1xHA28 mice retain the ability to upregulate Foxp3, and may actually be primed to do 
so compared with 6.5+Foxp3- cells that have developed in the absence of exposure to 
cognate Ag.  
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3.2.12   The presence of Treg cells that recognize self-Ag can affect the fate of 
CD4+Foxp3- T cells with the same TCR specificity 
 
 To determine whether the presence of Treg cells with the same TCR specificity 
might affect the fate of autoreactive CD4+Foxp3- T cells, we transferred 
6.5+CD4+CD25-eGFP- cells isolated from TS1.Foxp3eGFP.Ly5.1 mice into HA28 recipients 
either alone or in conjunction with either polyclonal CD4+eGFP+ Treg cells from BALB/c. 
Foxp3eGFP mice or 6.5+CD4+eGFP+ cells from TS1xHA28.Foxp3eGFP mice (Fig. 3-12 A).  
We found that the presence of 6.5+ Treg cells, but not polyclonal Treg cells, reduced the 
number of transferred Ly5.1+6.5+Foxp3- cells that accumulated in the pLNs at day 7 
post-transfer (Fig. 3-12 B).  However, co-injection of 6.5+ Treg cells did not significantly 
affect the number of Ly5.1+6.5+Foxp3+ cells that accumulated in HA28 recipients, 
resulting in an increased percentage of Ly5.1+6.5+ cells that expressed Foxp3 (Fig. 3-12 
B).  In contrast to this result, when 6.5+CD4+CD25-eGFP- T cells were transferred into 
TS1xHA28 mice, no upregulation of Foxp3 was observed (Fig. 3-12 C).  These results 
show that the presence of 6.5+ Treg cells limits 6.5+CD4+Foxp3- T cell accumulation but 
not 6.5+CD4+Foxp3+ pTreg cell accumulation in an HA28 mouse.  In contrast, no 
upregulation of Foxp3 by 6.5+CD4+ T cells occurred following transfer into TS1xHA28 
mice, suggesting that while a small number of Treg cells of identical specificity can result 
in preferential accumulation of 6.5+CD4+Foxp3+ cells relative to 6.5+CD4+Foxp3- cells, a 
saturation point may exist beyond which no more pTreg cells of that specificity will form.   
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3.3  Summary of Results and Discussion 
 
3.3.1  The stimulatory potency of cognate self-Ag determines the fate of 
autoreactive thymocytes 
 
 Recognition of cognate self-Ag can drive thymocyte deletion or, alternatively, 
differentiation into a Foxp3+ Treg cell (Jordan et al. 2001; Kawahata et al. 2002).  
Thymocytes expressing the transgenic, HA-specific 6.5+ TCR undergo deletion in the 
thymus of a TS1xHACII mouse, in which the self-HA is expressed at high levels and 
under control of an MHCII promoter that directs its expression preferentially to APCs 
(Fig. 3-2).  Foxp3 expression in 6.5+CD4SP thymocytes in TS1xHACII mice is slightly 
higher than in single transgenic TS1 mice, indicating that recognition of self-HA can 
induce Foxp3 upregulation.  However, the extensive deletion that occurs in these mice 
ultimately results in no significant increase in the number of 6.5+CD4SPFoxp3+ 
thymocytes or 6.5+CD4+Foxp3+ cells in the pLNs.  In contrast, some 6.5+ thymocytes in 
TS1xHA28 mice, in which self-HA is expressed at much lower levels and predominantly 
by non-bone marrow-derived cells (Lerman et al. 2004), undergo deletion, but 
significantly less than in a TS1xHACII mouse.  Furthermore, the percentage of 
6.5+CD4SP thymocytes expressing Foxp3 was significantly higher than in TS1xHA28 
mice than in TS1 or TS1xHACII mice, as was the number of 6.5+CD4SPFoxp3+ 
thymocytes and of 6.5+CD4+Foxp3+ cells in the periphery (Fig. 3-2).  Thus, recognition of 
a self-Ag expressed at relatively low levels induced limited thymocyte deletion and 
differentiation into Foxp3+ Treg cells, while recognition of the same self-Ag expressed at 
relatively higher levels resulted in extensive deletion and no significant increase in the 
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number of CD4SPFoxp3+ cells in the thymus or the periphery.  This idea is consistent 
with previous publications from the lab using transgenic mice (Picca et al. 2009), as well 
as with one study demonstrating that injection of high doses of HEL (and subsequent 
processing and presentation within the thymus) resulted in more efficient deletion of 
thymocytes expressing an HEL-specific TCR, while injection of relatively lower doses of 
HEL resulted in increased accumulation of HEL-specific CD4+Foxp3+ cells (Atibalentja, 
Byersdorfer, Unanue 2009).   
 
 Further characterization of 6.5+ thymocyte development in TS1 and TS1xHA28 
mice revealed that CD25 was upregulated on approximately 20% of 6.5+CD4SPFoxp3- 
thymocytes and 65% of 6.5+CD4SPFoxp3+ thymocytes (Fig. 3-3 A).  The transcription 
factor Helios, which has previously been found to be upregulated in thymocytes following 
strong TCR stimulation (Daley, Hu, Goodnow 2013), was upregulated in nearly 70% of 
6.5+CD4SPFoxp3- thymocytes and 100% of 6.5+CD4SPFoxp3+ thymocytes (Fig. 3-3 A).  
These data show that the majority of the 6.5+CD4SP thymocytes in TS1xHA28 mice have 
encountered cognate self-HA that induced CD25 and/or Helios upregulation, as 
6.5+CD4SP thymocytes in TS1 mice express neither Helios nor CD25.  The majority of 
6.5+CD4+Foxp3+ T cells in the pLNs of TS1xHA28 mice expressed CD25 and Helios, 
and no expression of these molecules was observed in 6.5+CD4+Foxp3- cells.  We 
observed similar patterns of CD25 and Helios expression among CD4SP thymocytes in 
BALB/c mice with unmanipulated TCR repertoires (Fig. 3-3 B).  Thus, recognition of self-
Ag can induce upregulation of CD25 and Helios independently of Foxp3 expression in 
CD4SP thymocytes, and autoreactive Helios+CD4SPFoxp3- thymocytes can be observed 
both in TS1xHA28 mice and in BALB/c mice in the absence of a TCR transgene.  
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However, mature CD4+Foxp3- cells either have lost expression of CD25 and Helios, or 
derive from a small population of 6.5+CD4SP thymocytes that do not express CD25 or 
Helios.  The fate of the Helios+CD4SPFoxp3- thymocytes remains unclear, but one 
possibility is that they enter peripheral circulation as autoreactive CD4+ T cells.  
  
3.3.2  Stimulatory potency of a self-Ag determines the extent to which reactive 
CD4+Foxp3- T cells differentiate into pTreg cells in vivo 
 
 Using the HA28 and HACII transgenic mice, we assessed the ability of the HA 
self-Ag to induce 6.5+CD4+Foxp3- T cells to differentiate into Foxp3+ pTreg cells.  In 
HA28 mice, a subset of 6.5+CD25-Foxp3- cells had upregulated Foxp3 expression at day 
3 post-transfer, but this group was limited to cells that had undergone 0-2 rounds of 
division, while many of those that remained Foxp3- had divided 3-5 times (Fig. 3-4 C,D).  
In contrast, 6.5+CD25-Foxp3- T cells transferred into HACII hosts had divided more 
extensively, and did not upregulate Foxp3.  These data are consistent with a previous 
study in which pTreg cells differentiated following injection of cognate peptide that 
showed that a low dose of peptide induced more pTreg cell formation than a high dose, 
and that those cells that upregulated Foxp3 had undergone fewer rounds of division than 
those that did not (Gottschalk, Corse, Allison 2010).  At day 21 post-transfer into HA28 
recipients, nearly 50% of 6.5+CD4+Ly5.1+ donor-derived T cells expressed Foxp3, and 
the number of CD4+Ly5.1+ cell had begun to decrease, indicating that expression of 
Foxp3 was relatively stable, while those Ly5.1+ cells that remained Foxp3- were 
gradually deleted (Fig. 3-6 B).  Moreover, the 6.5+ pTreg cells that formed in HA28 
recipients were able to suppress proliferation of 6.5+CD4+Foxp3- cells in vitro as well as 
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tTreg cells isolated from TS1xHA28 mice (Fig. 3-6 C).  The use of eGFP-tolerant 
animals as recipients was crucial for examining the fate of Ly5.1+ Treg cells at days 14 
and 21 post-transfer, as evidence of deletion of donor cells that upregulated eGFP was 
found in both HA28 and HACII recipients, despite the fact that no upregulation of Foxp3 
(and thus eGFP) was ever identified in HACII hosts (Fig. 3-5).  These data suggest that 
Foxp3 may be transiently expressed by 6.5+CD4+Foxp3- transferred into HACII mice 
without leading to pTreg cell differentiation, as has been previously reported in both 
mouse and human T cells (Miyao et al. 2012; Wang et al. 2007).   
 
The pTreg cells that formed in HA28 mice upregulated CD25 and Helios, such 
that by day 21 post-transfer, nearly 100% of Ly5.1+Foxp3+ cells, and none of the 
Ly5.1+Foxp3- cells, isolated from the pLNs expressed these molecules.  This 
Helios+CD25+ phenotype is very similar to that of 6.5+CD4+Foxp3+ tTreg cells that 
formed in TS1xHA28 mice (Fig. 3-3 and Fig. 3-8).  Additionally, Ly5.1+ cells that 
upregulated Foxp3 in HA28 mice displayed a decreased ability to produce the 
inflammatory cytokines IL-2 and IFN-γ upon restimulation with PMA/ionomycin ex vivo 
relative to those cells that did not upregulate Foxp3, consistent with previous 
descriptions of Treg cells (Hori, Nomura, Sakaguchi 2003) (Fig. 3-7).  Interestingly, a 
lower percentage of Ly5.1+Foxp3- cells in HACII mice than in HA28 mice were capable 
of producing IL-2 and IFN-γ at day 14 post-transfer, and little IL-17 production by these 
cells was observed (Fig. 3-7).  While 6.5+CD4+Foxp3- cells adoptively transferred into 
HACII recipients expanded to huge numbers and resulted in enlargement of the spleen 
and LNs, no signs of autoimmune disease were observed, which could be explained by 
the reduced cytokine production observed in these mice.  6.5+ T cells adoptively 
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transferred into HACII mice may differentiate into a different helper T cell, thus 
explaining their decreased production of IL-2 and IFN-γ.  Alternatively, in other systems, 
transfer of TCR-transgenic CD4+ T cells into recipient mice that expressed cognate Ag 
as self resulted in T cell expansion prior to adoption of an anergic phenotype 
characterized by decreased cytokine production and proliferation upon subsequent 
stimulation (Lanoue et al. 1997; Tanchot et al. 2004).  We did not directly assess the 
ability of 6.5+ T cells to proliferate after 14 days in HACII hosts, although the number of 
CD4+Ly5.1+ cells in the pLNs of HACII recipients began to decrease following day 14, so 
it is possible that the rate of division had slowed by this time point.  Moreover, CD4+ T 
cells specific for viral Ag can become exhausted during a chronic viral infection, a 
condition that is again characterized by decreased proliferation and IL-2 and IFN-γ 
production in response to TCR stimulation following initial activation (Crawford et al. 
2014).  More studies would be needed to determine whether 6.5+ T cells transferred into 
HACII mice may adopt one of these alternative fates.  
 
3.3.3  pTreg cell differentiation in the mesenteric LN 
 
Previous studies have demonstrated that specialized mechanisms dependent on 
retinoic acid and TGF-β exist in gut associated lymphoid tissues, such as the mesLN, to 
support the development of Treg cells (Coombes et al. 2007; Sun et al. 2007).  Thus, we 
examined accumulation of Ly5.1+Foxp3+ Treg cells in the mesLNs of HA28 and HACII 
mice that received 6.5+CD4+CD25-Foxp3-Ly5.1+ cells isolated from TS1.Foxp3eGFP.Ly5.1 
donors at various time points post-transfer.  CD4+Ly5.1+ T cell accumulation and the 
extent of Foxp3 upregulation was similar in the mesLNs to what we had observed in the 
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pLNs, although the percentage of CD4+Ly5.1+ expressing Foxp3 was significantly higher 
in the mesLN of an HACII recipient than a BALB/c recipient at day 3 post-transfer, which 
was not true in the pLNs (Fig. 3-9 A).  This observation suggests that the requirement for 
a lower degree of stimulation in pTreg cell induction may be less stringent in the mesLNs 
than the pLNs.  However, by days 7, 14, and 21 post-transfer, the percentage of 
CD4+Ly5.1+ cells from the mesLN expressing Foxp3 was no longer higher in an HACII 
mouse than a BALB/c mouse, which demonstrates that highly immunostimulatory self-
Ag cannot support the continued differentiation or survival of Ag-specific pTreg cells.  
Interestingly, we found that a higher percentage of 6.5+ pTreg cells in the mesLN than 
the pLNs of an HA28 mouse remained Helios- (Fig. 3-9 B).  Helios was originally 
described as a marker of tTreg cells, and controversy remains over whether and under 
what circumstances it may be upregulated in pTreg cells (Gottschalk, Corse, Allison 
2012; Shevach and Thornton 2014; Thornton et al. 2010).  Our data suggests that the 
anatomical location in which a pTreg cell resides may determine whether or not it 
upregulates Helios; the self-HA and the 6.5+ TCR on the transferred T cells did not differ 
between the pLNs and the mesLN of an HA28 mouse, but Helios was upregulated to a 
lesser extent by 6.5+CD4+Ly5.1+ cells in the mesLNs.  Specialized CD103+ DCs are 
present in the gut, and mediate pTreg cell differentiation through retinoic acid and TGF-β 
dependent mechanisms, leading us to speculate that these CD103+ DCs may play a role 
in the formation of Foxp3+Helios- pTreg cells.  
 
In addition to assessing Foxp3 upregulation following adoptive transfer of 
6.5+CD4+CD25-Foxp3-Ly5.1+ cells into HA28 and HACII hosts, we additionally 
transferred these cells into HA12 mice to determine the extent of their accumulation and 
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Foxp3 upregulation.  HA12 mice express an intermediate amount of self-HA in the 
spleens, pLNs, mesLNs and intestines that is higher than what was found in an HA28 
mouse but lower than in an HACII mouse.  Additionally, HA expression on both radio-
resistant and radio-sensitive cell types can drive 6.5+ Treg cell formation in the thymus of 
TS1xHA12 mice, while in TS1xHA28 mice, HA expression on radio-resistant cell types is 
predominantly responsible for driving 6.5+ Treg cell formation (Picca et al. 2009).  We 
found that a higher percentage of donor-derived CD4+Ly5.1+ cells isolated from the pLNs 
had upregulated Foxp3 in HA28 mice versus HA12 mice, however when CD4+Ly5.1+ 
cells were isolated from the mesLNs instead, a higher percentage had upregulated 
Foxp3 in HA12 mice (Fig. 3-10).  It may be that the optimal dose of a self-Ag for inducing 
Ag-dependent Treg cell formation is slightly higher in the mesLN than in the pLNs.  
Alternatively, it is possible that HA is expressed in CD103+ DCs in the mesLNs of HA12 
mice, thus increasing presentation of HA by these cells that preferentially induce pTreg 
cell formation.  However, HA would also be expressed by CD103+ DCs in HACII mice 
since it is under control of the MHCII promoter in this lineage, and yet little or no 6.5+ 
pTreg cell formation occurred in the mesLNs of HACII mice, demonstrating that the 
immunostimulatory potency of the cognate self-Ag is still an important factor in 
determining the extent of pTreg cell formation.   
 
3.3.4  Effects of prior exposure to cognate self-Ag and the presence of tTreg cells 
of the same specificity on pTreg cell formation 
 
 A substantial population of 6.5+CD4+ T cells that remain Foxp3- exists in the 
pLNs of TS1xHA28 mice despite having access to cognate self-Ag both in the thymus 
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and the pLNs.  One possible explanation for their failure to upregulate Foxp3 was that 
they were intrinsically incapable of doing so, perhaps due to epigenetic differences that 
prevented access to the Foxp3 promoter.  To determine whether these cells were 
capable of upregulating Foxp3, we transferred CellTrace Violet-labeled 6.5+CD4+CD25-
Foxp3- cells, which were isolated from either TS1.Foxp3eGFPmice or 
TS1xHA28.Foxp3eGFPmice, into HA28 recipients, and assessed their accumulation and 
upregulation of Foxp3 at day 3 or 14 post-transfer.  Division and accumulation of 
6.5+CD4+ cells from the two donor lineages was similar at day 3 post-transfer, but Foxp3 
expression was significantly higher among 6.5+CD4+ cells derived from from TS1xHA28 
donors relative to TS1 donors (Fig. 3-11 B).  These data suggest that CD4+Foxp3- cells 
that develop in the presence of cognate self-Ag may be primed for Foxp3 upregulation 
relative to naïve CD4+Foxp3- cells.  Ultimately, however, CD4+Foxp3- cells that 
developed in the presence of cognate self-Ag were neither more nor less capable of 
upregulating Foxp3 than their naïve counterparts, as accumulation and Foxp3 
upregulation were identical between the two sources of 6.5+CD4+Foxp3- cells by day 14 
post-transfer (Fig. 3-11 B).  Thus, it appears that no intrinsic reason exists to explain why 
some 6.5+CD4+ T cells in TS1xHA28 do not upregulate Foxp3. 
 
 An alternative explanation for why 6.5+CD4+Foxp3- T cells in the pLNs of 
TS1xHA28 mice failed to upregulate Foxp3 was that the presence of 6.5+CD4+Foxp3+ 
cells might limit their differentiation.  When 6.5+CD4+CD25-Foxp3-Ly5.1+ cells were 
isolated from TS1.Foxp3eGFP.Ly5.1 mice and transferred into HA28 recipients, the 
simultaneous transfer of 6.5+ Treg cells, but not of polyclonal Treg cells, limited their 
accumulation in the pLNs, demonstrating that 6.5+ Treg cells suppressed 6.5+ T cell 
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accumulation more effectively than Treg cells of other diverse specificities (Fig. 3-12 B).  
Furthermore, the percentage of 6.5+CD4+Ly5.1+ cells expressing Foxp3 was higher in 
HA28 mice that also received 6.5+ Treg cells than in HA28 mice that received either 
polyclonal Treg cells or no Treg cells.  However, the number of 6.5+CD4+Ly5.1+Foxp3+ 
pTreg cells that formed in HA28 mice at day 7 post-infection was no higher when 6.5+ 
Treg cells were co-transferred than when polyclonal Treg cells or no Treg cells were co-
transferred, indicating that the presence of 6.5+ Treg cells limited accumulation of 
6.5+CD4+Foxp3- cells, but did not impact 6.5+CD4+Foxp3+ pTreg cell formation (Fig. 3-12 
B).  In contrast, adoptively transferred 6.5+CD4+Ly5.1+ cells accumulated less in the 
pLNs of a TS1xHA28 recipient than an HA28 recipient, and no upregulation of Foxp3 
occurred, suggesting that the 6.5+ Treg cell niche may be saturated in TS1xHA28 mice, 
and that 6.5+CD4+Foxp3- cells may not have sufficient access to cognate self-Ag or to 
cytokines, such as IL-2, to induce differentiation (Fig. 3-12 C).  A limited niche for Treg 
cells of a given specificity has been found to exist in the thymus, and increasing the 
clonal precursor frequency of thymocytes expressing a transgenic TCR can result in a 
decreased number of clonotypic thymocytes upregulating Foxp3 (Bautista et al. 2009; 
Leung, Shen, Lafaille 2009).  In this case, competition for cognate Ag may limit the size 
of the clonotypic tTreg cell niche, and the same phenomenon could occur in the 
periphery. 
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CHAPTER 4:  Variations in Ag presentation determine Treg cell activity in vivo 
 
4.1  Introduction 
 
 In addition to their well-established role in maintaining immune homeostasis at 
steady-state, Treg cells have more recently been revealed to participate in and modulate 
immune responses generated against pathogens (Maizels and Smith 2011).  However, 
the signals required for Treg cell accumulation and activity during an infection remain 
poorly understood.  TCR stimulation is required for Treg cell activity in vitro (Thornton 
and Shevach 1998), and TCR-transgenic Treg cells failed to expand or enter the lungs 
during M. tuberculosis or influenza virus infection in the absence of cognate Ag (Bedoya 
et al. 2013; Shafiani et al. 2010).  Thus, it appears that a TCR signal is required for Treg 
cell accumulation during an infection, and that exposure to an inflammatory environment 
is not sufficient for their activation.  It has been suggested that CD4+Foxp3- T cells may 
differentiate into pTreg cells upon recognition of pathogen-derived Ag (Mills and McGuirk 
2004), and there is good evidence that recognition of commensal microbiota can induce 
pTreg cell formation (Lathrop et al. 2011).  Thus, peripheral differentiation of pathogen-
specific pTreg cells represents one possible source of Treg cells that accumulate during 
infection.  Alternatively, Treg cells that exist in the pre-immune repertoire may expand 
and modulate the effector immune response following recognition of either pathogen-
derived Ag or self-Ag present at sites of infection.  Indeed, in both L. major and M. 
tuberculosis infection models, the Treg cells isolated from infection sites derived from 
pre-existing Treg cells (Belkaid et al. 2002; Shafiani et al. 2010; Suffia et al. 2006).  A 
subset of the Treg cells present at the site of L. major infection were found to be specific 
for microbial Ag, but this observation does not necessarily rule out a role for self-reactive 
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Treg cells during infection, and whether activation on self-antigen can drive Treg cell 
activity during infection has not been explored (Suffia et al. 2006). 
 
Previous studies in our lab have demonstrated that 6.5+ Treg cells isolated from 
TS1xHA28 mice expanded and accumulated in the lungs and lung-draining mediastinal 
LNs (medLNs) during infection with PR8 influenza virus, which contains the cognate HA 
(Bedoya et al. 2013).  Thus, Treg cells selected on a self-Ag in the thymus can become 
activated during infection in response to cognate viral Ag.  Adoptive transfer of 6.5+ Treg 
cells prior to PR8 virus infection reduced the accumulation of CD4+Foxp3- T cells and 
both total and virus-specific CD8+ T cells in the lungs at day 8 post-infection (Bedoya et 
al. 2013). Notably, the presence of 6.5+ Treg cells resulted in a decrease in CD4+Foxp3- 
and CD8+ T cell proliferation in the lungs but not in the medLNs at this time point, and 
expression of the chemokine receptor CXCR3 on effector cells in the medLN was not 
affected.  These findings suggest that 6.5+ Treg cells limit effector cell accumulation by 
suppressing proliferation within the lungs rather than by limiting migration of T cells into 
the lungs from the medLN.  6.5+ Treg cells isolated from the lungs during PR8 virus 
infection were found to be capable of producing IL-10, suggesting one potential 
mechanism by which they may be exerting suppression (Bedoya et al. 2013); IL-10 limits 
immunopathology in the lungs during influenza virus infection, and treatment with IL-10R 
blocking antibody was found to result in increased mortality and more rapid death in 
infected mice (Sun et al. 2009).  These findings are reminiscent of another study in 
which pathogen-specific Treg cells delayed accumulation of pathogen-specific CD4+ and 
CD8+ T cells in the draining lymph nodes and lungs during M. tuberculosis infection 
(Shafiani et al. 2010).   
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It has recently become apparent that Treg cells can differentiate further and 
acquire novel characteristics that allow them to effectively suppress the activity of 
different T helper cell subsets in a process termed functional specialization (Campbell 
and Koch 2011).  Selective ablation of IRF4, which is associated with Th2 cell 
differentiation, in Foxp3+ cells results in uncontrolled Th2 cell activity, while expression of 
STAT3 by Treg cells was required to prevent Th17-mediated autoimmune 
lymphoproliferative disease (Chaudhry et al. 2009; Zheng et al. 2009).  Alternatively, 
Treg cells can acquire expression of T-bet and CXCR3, and these T-bet+ Treg cells are 
required to prevent Th1 cell-mediated immunopathology and limit IFN-γ production by 
CD4+ T cells at steady state (Koch et al. 2009).  We have found that 6.5+ Treg cells 
differentiate towards this T-bet+ phenotype during a PR8 influenza virus infection, and 
increase expression of T-bet, CXCR3, IL-10, and Blimp1 compared to donor 6.5+ Treg 
cells (Bedoya et al. 2013).  The transcription factor T-bet is necessary for CXCR3 
expression, and IFN-γ is thought to be at least partially responsible for induction of T-bet 
expression, as IFN-γR-/- Treg cells express much lower levels of both T-bet and CXCR3 
(Koch et al. 2009).  Additional studies suggested that T-bet is dispensable for IL-10 
production, and instead Blimp1 appears to be required (Cretney et al. 2011).  
 
In this section, we describe studies examining the extent to which recognition of 
HA derived from self or from influenza virus can activate 6.5+ Treg cells to proliferate, 
differentiate, and modulate the anti-viral immune response.  Although a weakly 
stimulatory form of self-HA induced 6.5+ Treg cell formation both in the thymus and the 
periphery, recognition of self-HA in this context did not induce 6.5+ Treg cells to 
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accumulate or differentiate in the lungs and medLN during infection with influenza virus 
that lacked the cognate HA epitope.  In contrast, when HA was present as a viral Ag, 
6.5+ Treg cells proliferated extensively, acquired a T-bet+CXCR3+ phenotype, and 
suppressed the accumulation of effector T cells in the lungs.  Increasing the stimulatory 
potency of the self-HA by using HACII mice did not result in efficient Treg cell activation 
during influenza virus infection, and instead inhibited the ability of 6.5+ Treg cells to 
differentiate and mediate suppression upon subsequent exposure to PR8 virus-derived 
HA.  Further studies revealed that Ag presentation by B cells in HACII mice, and a non-
inflammatory environment at the time of initial TCR stimulation, both likely contributed to 
the lack of 6.5+ Treg cell differentiation and activity in HACII mice.  Together, the studies 
presented in this section demonstrate that the type of APC presenting Ag to a Treg cell 
and whether presentation occurs in the presence of an inflammatory response can affect 
the extent of Treg cell differentiation, and further reveal that exposure to a highly 
stimulatory cognate self-Ag can result in changes to the Treg cell phenotype.   
 
4.2  Results 
 
4.2.1  Treg cells accumulate in the mediastinal LNs and lungs during PR8 
influenza virus infection 
 
To assess the accumulation of Treg cells during an immune response to 
influenza virus, we infected otherwise unmanipulated BALB/c mice with PR8 influenza 
virus and examined expression of CD25 and Foxp3 on CD4+ T cells isolated from the 
medLNs and lungs (Fig. 4-1).  The number of CD4+Foxp3+ Treg cells in each location 
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was 5-6 times higher at day 8 post-infection with PR8 influenza virus than in uninfected 
mice.  Thus, Treg cells were recruited to and/or expanded at sites of influenza virus 
infection in BALB/c mice. 
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4.2.2.  6.5+CD4+Foxp3- T cells do not differentiate into Foxp3+ Treg cells following 
recognition of viral Ag 
 
One possible source of the Treg cells that accumulated during influenza virus 
infection was CD4+Foxp3- cells that converted into Foxp3+ pTreg cells upon recognition 
of viral Ag.  To determine whether recognition of viral Ag might drive CD4+Foxp3- T cells 
to differentiate into Foxp3+ Treg cells, we transferred CellTrace Violet-labeled 
6.5+CD4+CD25-eGFP- T cells isolated from TS1.Foxp3eGFP mice into BALB/c recipients 
that were infected intranasally the following day with PR8 influenza virus, which contains 
the HA epitope recognized by the 6.5+ TCR (Fig. 4-2 A).  At day 5 post-infection, 
6.5+CD4+ T cells isolated from the medLNs, lungs, and spleens were analyzed for 
dilution of CellTrace Violet and expression of Foxp3.  The 6.5+CD4+ T cells isolated from 
each location had all undergone multiple rounds of division, indicating that they had 
been exposed to cognate viral HA as part of a peptide:MHC complex, but no 
upregulation of Foxp3 occurred (Fig. 4-2 B).  These data show that recognition of viral-
HA induced 6.5+CD4+Foxp3- T cell division but not Foxp3 upregulation, and suggests 
that the Treg cells that accumulate at infection sites likely derive from expansion of pre-
existing Treg cells, and not from conversion of virus-reactive CD4+Foxp3- T cells into 
pTreg cells.   
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4.2.3.  The self-HA in HA28 mice is optimal for 6.5+ Treg cell formation, but not for 
6.5+ Treg cell recruitment or expansion during an influenza virus infection 
 
The studies in Chapter 3 showed that the HA self-peptide in HA28 mice can 
support the formation of 6.5+CD4+Foxp3+ Treg cells both during thymocyte development 
and in the periphery by promoting conversion of conventional CD4+ T cells into Foxp3+ 
Treg cells, and we were interested in whether the HA self-peptide in these mice could 
also activate Treg cells to exert regulatory function during an infection.  To examine this 
question, we modified an adoptive transfer system that had previously been used in the 
lab to demonstrate that CD4+Foxp3+ Treg cells generated in TS1xHA28 mice could 
modulate immune responses to influenza virus following recognition of PR8 virus-
derived HA.  In the previous studies, BALB/c mice were seeded with CD4+Foxp3+ Treg 
cells from TS1xHA28 mice and then infected with PR8 virus on the following day, and 
the accumulation of donor-derived Treg cells, their differentiation, and their effects on the 
immune response was evaluated (Bedoya et al. 2013).  To assess the ability of HA to 
activate the 6.5+ Treg cells when it was present as a self-Ag but not as a viral-Ag, we 
repeated these studies in HA28 mice that had received CD4+Foxp3+Ly5.1+ Treg cells 
from TS1xHA28.Foxp3eGFP.Ly5.1 mice and were then infected with a PR8 mutant virus 
(RV6) bearing a single amino acid substitution in the S1 determinant of the HA that is 
recognized by the 6.5 TCR (Hurwitz et al. 1984).  This mutation impairs recognition of 
the viral Ag by the transferred Treg cells, and thus the extent to which 6.5+ Treg cells 
can become activated by the self-HA Ag could be assessed by comparison with Treg 
cell-recipient RV6-infected BALB/c mice (which do not express the HA self-Ag), and with 
Treg cell-recipient PR8-infected BALB/c mice (in which the transferred Treg cells can 
recognize the HA as a viral Ag, but not as a self-Ag).  We first transferred CellTrace 
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Violet-labeled CD4+eGFP+ cells isolated from TS1xHA28.Foxp3eGFP.Ly5.1 mice into 
BALB/c or HA28 recipients, which were infected the following day with PR8 virus, RV6 
virus, or J1 virus (a reassortant virus that is genetically identical to PR8 except that it 
contains a serologically non-crossreactive H3 subtype HA (Palese 1977)) (Fig. 4-3 A,C).  
At day 5 post-infection, dilution of CellTrace Violet and Foxp3 expression were assessed 
in 6.5+CD4+ cells isolated from the medLNs, lungs, and spleens of the recipient mice.  In 
BALB/c mice infected with PR8 virus, the majority of cells isolated from each anatomical 
location had divided and most had undergone between 4 to 8 rounds of division (Fig. 4-3 
B).  Within the lungs of these mice, no undivided 6.5+CD4+ cells were found, and these 
cells had undergone on average more divisions than those in the medLNs and spleens.  
RV6 virus induced some division of 6.5+CD4+ cells in the medLNs of infected BALB/c 
mice, but cells isolated from the lungs and spleens had undergone little or no division 
(Fig. 4-3 B).  Importantly, the extent of 6.5+CD4+ Treg cell division that occurred in 
response to RV6 virus was much less than what occurred in response to PR8 virus 
infection, reflecting the reduced reactivity of the 6.5 TCR toward the RV6 mutant.  
Finally, in J1 virus infected BALB/c mice, 6.5+CD4+ Treg cells did not divide in any of the 
locations examined, despite a clear evidence of infection (data not shown), indicating 
that inflammatory signals alone in the absence of TCR stimulation were not sufficient to 
drive 6.5+ Treg cell division at sites of infection (Fig. 4-3 B).  In the same set of 
experiments, we also transferred CellTrace Violet-labeled CD4+eGFP+ cells isolated 
from TS1xHA28.Foxp3eGFP.Ly5.1 mice into uninfected HA28 recipients; we found that 
6.5+CD4+ Treg cells isolated from the medLN and spleens at day 6 post-transfer had 
undergone approximately 0 to 2 rounds of division, indicating that recognition of self-Ag 
could induce 6.5+ Treg cell proliferation in HA28 mice, but that very few of these cells 
could be identified in the lungs (Fig. 4-3 D).  Notably, even though HA28 mice expressed 
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the HA as a self-peptide, there was no greater accumulation of 6.5+ Treg cells in the 
medLNs and lungs of RV6-infected HA28 mice than occurred in RV6-infected BALB/c 
mice. 
 
We additionally assessed the accumulation of donor-derived Ly5.1+CD4+ cells in 
the medLN and lungs at day 8 post-infection, and found that the number of 6.5+CD4+ 
Treg cells in the lungs of PR8 virus-infected BALB/c mice increased nearly 8 fold 
between days 5 and 8 post-infection, while the increase in the medLNs was much less 
dramatic (Fig. 4-3 E,F).  These data suggest that 6.5+ Treg cells accumulate first in the 
medLNs, then in the lungs during infection with virus containing the cognate HA Ag.  In 
contrast, 6.5+CD4+ Treg cells did not accumulate in the lungs of RV6 virus-infected 
BALB/c or HA28 mice at day 8 post-infection, and recognition of self-HA in HA28 mice 
did not cause 6.5+ Treg cells to accumulate to a greater extent during RV6 virus-infection 
relative to BALB/c hosts (Fig. 4-3 E).  At both days 5 and 8 post-infection, significantly 
more donor-derived Treg cells were present in the medLN and lungs of PR8-infected 
BALB/c mice compared with both RV6-infected BALB/c mice and RV6-infected HA28 
mice, and in all conditions, transferred Treg cells maintained expression of Foxp3 (Fig. 
4-3 F).  Notably, both RV6 and PR8 virus induced similar amounts of weight loss and 
IFN-γ accumulation in the serum, suggesting that any differences observed in the 6.5+ 
Treg cell response to the different viruses were not the result of disparities in the overall 
infection and immune response (Fig. 4-3 G,H). 
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These data show that recognition of self-HA can induce 6.5+ Treg cell division in 
HA28 mice, but recognition of viral-HA during PR8 virus infection induced more 
extensive division.  In PR8 virus-infected BALB/c mice, the majority of 6.5+ Treg cell 
accumulation in the medLN occurred by day 5 post-infection, while accumulation in the 
lungs mostly took place between days 5 and 8 post-infection.  In contrast, in RV6 virus-
infected infected HA28 mice, 6.5+ Treg cells isolated from the medLN had divided, but 
significantly less cells were present than in the case of PR8 virus infection, and 6.5+ Treg 
cells did not accumulate in the lungs of RV6 virus-infected BALB/c or HA28 mice.  
 
4.2.4  Recognition of virus HA, but not self-HA in HA28 mice, induced 6.5+ Treg cell 
differentiation during influenza virus infection 
 
Studies from our lab have previously shown that 6.5+CD4+Foxp3+ Treg cells 
differentiat into T-bet+CXCR3+ Treg cells in PR8-infected BALB/c mice (Bedoya et al. 
2013).  Consistent with these previous studies, the 6.5+CD4+Foxp3+ Treg cells that had 
undergone division in the medLNs of PR8-infected BALB/c mice at day 5 p.i. had 
uniformly upregulated CXCR3 and contained cells with increased T-bet expression, and 
CXCR3 and T-bet were also upregulated in the 6.5+CD4+Foxp3+ Treg cells in the lungs 
of PR8-infected BALB/c mice at day 8 p.i. (Fig. 4-4).  By contrast, significantly lower 
percentages of the 6.5+CD4+Foxp3+ Treg cells in RV6-infected BALB/c or HA28 mice 
expressed CXCR3, and no significant upregulation of T-bet occurred.  The ability to 
recognize self-HA did not result in CXCR3 upregulation in uninfected HA28 mice, and 
did not increase CXCR3 or T-bet upregulation by 6.5+ Treg cells in RV6-infected HA28 
mice relative to RV6-infected BALB/c mice.   
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Thus, recognition of the differentiation-inducing self-Ag did not result in 6.5+ Treg 
cell differentiation towards a T-bet+ phenotype, either in the presence or absence of 
infection.  In contrast, recognition of the same peptide when it was present as a viral Ag 
induced upregulation of T-bet and CXCR3. 
 
4.2.5  Recognition of PR8 virus-derived HA induced 6.5+ Treg cells to suppress the 
effector T cell response during influenza virus infection more efficiently than 
recognition of self-HA 
 
In the experiments described in the previous two sections, we also examined the 
frequencies of CD4+Foxp3- and CD8+ effector cells in the lungs of mice that had or had 
not received 6.5+CD4+Foxp3+ Treg cells.  In the absence of transferred Treg cells, the 
magnitudes of the CD4+Foxp3- and CD8+ effector T cell responses were similar between 
all of the mice irrespective of whether they had been infected with PR8 or RV6 (Fig. 4-5).  
Adoptive transfer of 6.5+CD4+Foxp3+ Treg cells prior to infection caused a decrease in 
the effector T cell response only in BALB/c mice infected with PR8 virus.  Thus, even 
though interactions with the self-HA can promote the formation and persistence of 
6.5+Foxp3+ Treg cells in HA28 mice, such interactions did not direct 6.5+CD4+Foxp3+ 
Treg cells to accumulate, differentiate, or limit effector T cell accumulation at infection 
sites during an infection with a non-cognate influenza virus, such as occurred when the 
6.5+CD4+Foxp3+ Treg cells could recognize HA derived from viral Ag. 
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4.2.6  Increasing the immunostimulatory strength of the self-HA inhibited 6.5+ Treg 
cell accumulation and differentiation in response to viral Ag 
 
It was possible that 6.5+ Treg cells expanded and suppressed the immune 
response following recognition of viral-HA in a PR8 virus-infected BALB/c mouse, but not 
following recognition of self-HA during an RV6 virus infection in an HA28 mouse, 
because Treg cell proliferation and activation requires the high levels of the HA Ag that 
are generated during infection.  To test whether increasing the level of expression of the 
HA as a self-Ag could promote 6.5+ Treg cell activity in virus-infected mice, we made use 
of HACII mice, in which the HA transgene is expressed at high levels by APCs.  To 
compare 6.5+ Treg cell division in response to PR8 virus HA versus self-HA in HACII 
mice, we first infected BALB/c mice with PR8 virus and infected HACII mice with the 
weakly crossreactive RV6 virus.  Then on the following day, we transferred CellTrace 
Violet-labeled, Ly5.1 congenically-marked 6.5+CD4+Foxp3+ T cells from 
TS1xHA28.Foxp3eGFP.Ly5.1 mice into the infected mice and into uninfected HACII mice.  
By performing the adoptive transfers the day after infection, we were able to assess 
division of 6.5+ Treg cells after exposure to viral-HA or self-HA for the same amount of 
time.  At day 5 post-infection (day 4 post-transfer) the Ly5.1+CD4+ Treg cells in the 
medLN and lungs of both uninfected and RV6-virus infected HACII mice had undergone 
similar levels of division as had occurred in PR8-infected BALB/c mice, suggesting that 
the self-HA in the medLN and lungs of HACII mice was equally capable of inducing 
division of 6.5+ Treg cells as was the virus-derived HA (Fig. 4-6 B).   
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The self-HA in HACII mice could also support the accumulation of 6.5+ Treg cells, 
as Ly5.1+ donor-derived cells made up a larger percentage of total CD4+ cells and were 
present at higher numbers in the spleens of uninfected HACII than of PR8 virus-infected 
BALB/c mice at day 8 p.i. (Fig. 4-6 C,D).  Notably, however, at day 8 p.i., significantly 
fewer CD4+Foxp3+Ly5.1+ cells had accumulated in the medLNs of either uninfected or 
RV6-infected HACII mice than occurred in PR8-infected BALB/c mice, and the 
percentage of CD4+ cells expressing Ly5.1 in the medLN did not increase in RV6 virus-
infected HACII mice relative to uninfected HACII mice (Fig. 4-6 D).  Furthermore, the 
6.5+ Treg cells that were found in the medLN of RV6 virus-infected HACII mice 
expressed significantly lower levels of CXCR3 and T-bet than were found in PR8-
infected BALB/c mice (Fig. 4-7 A,B).  Consistent with impaired differentiation, fewer 
CD4+Ly5.1+Foxp3+ cells accumulated in the lungs of either uninfected or RV6 virus-
infected HACII mice, and the cells that did accumulate again expressed lower levels of 
T-bet than occurred in PR8 virus-infected BALB/c mice. 
 
To further explore how differences in the presentation of HA as a self- versus 
viral peptide might affect 6.5+ Treg cell differentiation, we also examined the ability of 
6.5+ Treg cells to differentiate in HACII mice that had been infected with PR8 virus.  
Remarkably, the accumulation of Ly5.1+CD4+Foxp3+ cells in the medLN and lungs was 
significantly lower in PR8 virus-infected HACII mice than in PR8 virus-infected BALB/c 
mice (Fig. 4-6 D), and the levels of CXCR3 and T-bet that were expressed were much 
more similar to those observed in RV6-infected HACII mice than was the case in PR8-
infected BALB/c mice (Fig. 4-7 A,B).  Moreover, the provision of Treg cells led to a 
significant decrease in the accumulation of CD4+ and CD8+ effector cells in the lungs of 
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PR8-infected BALB/c mice, but these were not significantly reduced in RV6- or PR8-
infected HACII mice (Fig. 4-7 C).  These differences in the suppressive effects of 6.5+ 
Treg cell transfer in PR8 virus-infected BALB/c mice versus RV6 virus-infected HACII 
mice did not appear to be the result of differences in production of IL-10, which has been 
shown to limit inflammation in the lungs during influenza virus infection (Sun et al. 2009) 
(Fig 4-7 D).  Thus, recognition of the self-HA in HACII mice both failed to support the 
efficient recruitment of 6.5+ Treg cells in virus-infected mice, and actively suppressed the 
accumulation and differentiation of these cells in response to a viral Ag. 
 
4.2.7  Recognition of self-HA in HACII mice caused 6.5+ Treg cells to decrease 
expression of the 6.5+ TCR, CD25, and Foxp3 
 
6.5+ Treg cells failed to efficiently upregulate T-bet and CXCR3 in HACII mice, 
and this impaired differentiation likely plays a role in their decreased ability to suppress 
the effector T cell response in the lungs during infection.  However, adoptive transfer of 
6.5+ Treg cells into HACII hosts resulted in additional changes in the phenotype of the 
transferred cells that could potentially impair their suppressive capabilities.  When 
CD4+Foxp3+Ly5.1+ Treg cells from TS1xHA28.Foxp3eGFP.Ly5.1 mice were transferred 
into BALB/c or HACII recipients, and host mice were infected with influenza virus the 
following day, we found that expression of the 6.5+ TCR was significantly lower on 
Ly5.1+CD4+ cells isolated from the medLN, lungs, and spleens of HACII recipients than 
PR8 virus-infected BALB/c mice at day 8 p.i. (Fig. 4-8).   
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Furthermore, the percentage of Ly5.1+CD4+ cells that had downregulated Foxp3 
was significantly higher in the medLN and spleens of uninfected, RV6 virus-infected, or 
PR8 virus-infected HACII mice than in PR8 virus-infected BALB/c mice (Fig. 4-8).  
Interestingly, the presence of an RV6 or PR8 virus infection actually appeared to 
somewhat ameliorate the reduction in 6.5+ TCR and Foxp3 expression in the medLNs 
and lungs of HACII mice.  PD-1 expression on Ly5.1+CD4+ cells was higher in the 
spleens and medLNs of HACII mice, regardless of infection status, than of PR8 virus-
infected BALB/c mice, while expression of PD-1 was elevated on Ly5.1+CD4+ cells in the 
lungs of all mice (Fig. 4-8).  PD-1 expression in this context likely reflects increased TCR 
stimulation in HACII mice and in the lungs of PR8 virus-infected BALB/c mice, but high 
levels of PD-1 expression have been shown to limit the accumulation of Foxp3+ follicular 
regulatory T cells and to reduce their suppressive ability, and PD-1 could play a similar 
role in this context (Sage et al. 2013). 
 
4.2.8  The inflammatory environment at the time of initial TCR stimulation can 
determine the extent of Treg cell differentiation 
 
We considered the possibility that initial recognition of self-HA in a non-
inflammatory context could impede the ability of Treg cells to subsequently differentiate 
following TCR stimulation with viral Ag during infection.  To test this theory, we infected 
HACII mice with RV6 virus, then waited 4 days until the immune response to the virus 
was already well underway prior to injecting CD4+Foxp3+ T cells from 
TS1xHA28.Foxp3eGFP.Ly5.1 mice (Fig. 4-9 A).   
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We then compared CXCR3 expression on Ly5.1+CD4+ cells from these mice with 
CXCR3 expression on Ly5.1+CD4+ cells when they had been transferred into HACII 
hosts one day prior to infection.  At day 8 p.i., a higher percentage of Ly5.1+CD4+ cells in 
the medLN of HACII mice expressed CXCR3 when they had been adoptively transferred 
at day 4 p.i. than at day 1 prior to infection, although the level of CXCR3 expression 
observed in PR8-infected BALB/c mice was not achieved (Fig. 4-9 B, C).  Furthermore, 
the level of CXCR3 expression Ly5.1+CD4+ cells transferred at day 4 p.i. with RV6 virus 
was not significantly higher in an HACII mouse than in a BALB/c mouse.  This 
observation suggests that activation on self-HA in the presence of an established 
inflammation-inducing viral infection results in more Treg cell differentiation than 
exposure to self-HA prior to viral infection, but still induces less Treg cell differentiation 
than does activation by viral-HA.  
 
4.2.9  Recognition of self-HA can induce 6.5+ Treg cells to upregulate CXCR3 and 
T-bet during J1 influenza virus infection 
 
 Since CXCR3 expression by 6.5+ Treg cells during infection with the weakly 
cross-reactive RV6 virus was not increased in HACII hosts relative to BALB/c hosts, we 
wondered whether recognition of self-HA alone could ever induce Treg cell 
differentiation in the context of an infection.  To this end, 6.5+ Treg cells isolated from 
TS1xHA28.Foxp3eGFP donors were transferred into HACII mice, which were then infected 
with J1 influenza virus.  The J1 virus contains a serologically non-crossreactive H3 
subtype HA that is not recognized by the 6.5+ TCR (Palese 1977), and 6.5+ Treg cells in 
J1 virus-infected BALB/c mice do not divide or upregulate Foxp3 (Fig. 4-10 A).   
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However, 6.5+ Treg cells expressed higher levels of CXCR3 and T-bet in the medLNs 
and lungs of HACII mice infected with J1 virus than in uninfected HACII mice, and 
accumulated in the lungs to a greater extent (Fig. 4-10 B).  These data provide evidence 
that recognition of self-HA during infection can result in limited differentiation of 6.5+ Treg 
cells towards a T-bet+ phenotype.  
 
4.2.10  B cells and DCs are the predominant Ag presenting cells in the medLNs of 
influenza virus infected mice 
 
The differing capacities of the HA to induce 6.5+ Treg cell differentiation when 
expressed as a viral versus a self-Ag in infected mice might also have been a reflection 
of its presentation by different APC subsets.  To examine this possibility, we first 
characterized the leukocyte subsets present in the medLNs and lungs of HACII mice 
infected with RV6 virus, and of BALB/c mice infected with PR8 virus, at day 6 post-
infection.  The numbers and distribution of a variety of APC subsets were quite similar in 
both sets of mice, suggesting that differences in APC populations present were not the 
cause of the observed differences in Treg cell activity Fig. (4-11 A).  In each case, B 
cells were the most prevalent APC subset and substantially outnumbered dendritic cells 
(DCs), which were the second most numerous APC population in the medLNs and third 
most prevalent in the lungs behind inflammatory monocytes (iMOs).  We next wanted to 
assess the ability of different APC subsets to present Ag and induce T cell proliferation 
during influenza virus infection.   
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To this end, we isolated B cells, iMOs, neutrophils, and cDCs from the medLNs 
and lungs of PR8 virus-infected BALB/c mice and RV6 virus-infected HACII mice at day 
5 post-infection, and cultured them in vitro for 5 days with CellTrace Violet-labeled 
unfractionated cells isolated from the LNs of TS1xHA28.Foxp3eGFP mice (which contain 
6.5+CD4+Foxp3+ cells and 6.5+CD4+Foxp3- cells).  Of the cells isolated from the medLNs 
of PR8 virus-infected HACII mice, DCs were the only subset to induce substantial 
division by the CD4+ T cells (both Foxp3eGFP+ and Foxp3eGFP-) from TS1xHA28.Foxp3eGFP 
mice (Fig. 4-11 B).  In contrast, both B cells and DCs from the medLNs of RV6 virus-
infected HACII mice drove CD4+ T cell proliferation (Fig. 4-11 B).  When we assessed 
the ability of APCs isolated from the lungs of PR8 virus-infected BALB/c mice to induce 
CD4+ T cell proliferation, we found that DCs again drove the most division, but that B 
cells and, to a lesser extent, iMOs were also presenting PR8-derived HA Ag in a 
stimulatory manner (Fig. 4-11 C).  Interestingly, neutrophils by themselves did not induce 
CD4+ T cell division, but dilution of neutrophils in CD4-CD8- BALB/c splenocytes did 
result in minimal proliferation of co-cultured CD4+ cells, suggesting that neutrophils act 
as viral reserves to be taken up and presented by other cells, but do not present Ag to 
CD4+ T cells themselves (Fig. 4-11 C).  In the lungs of RV6 virus-infected HACII mice, B 
cells and DCs were also the primary Ag presenting cells.  These data show that DCs are 
the predominant cell type presenting viral Ag, and thus driving CD4+ T cell proliferation, 
in the medLNs of PR8 virus-infected mice, while both B cells and DCs isolated from the 
medLNs of RV6 virus-infected HACII mice can present self-HA and drive CD4+ T cell 
division.   
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4.2.11  Recognition of cognate Ag presented by DCs induces Treg cells to 
upregulate CXCR3  
 
Using the in vitro co-culture system described in the previous section, we 
assessed CXCR3 expression on CD4+Foxp3+ cells after they were cultured with cDCs or 
B cells from influenza virus-infected mice for 4 days (Fig. 4-12 A).  For these 
experiments, the cDCs were diluted either 1:16 or 1:64 with CD4-CD8- feeder cells 
isolated from splenocytes of uninfected BALB/c mice, while the B cells were used either 
undiluted or diluted 1:64 with feeder cells.  The majority of the Treg cells cultured with 
cDCs from the medLNs of PR8 virus-infected BALB/c mice underwent division and many 
upregulated CXCR3, whereas B cells isolated from the medLNs or PR8-infected BALB/c 
mice induced very little division or CXCR3 upregulation (Fig. 4-12 A).  These 
observations are consistent with previous studies that demonstrated that DCs collect 
viral Ag in the lungs during influenza virus infection, then migrate to the medLN where 
they constitute the predominant APC subset presenting viral Ag, while B cells in the 
medLN present very little viral Ag (Hamilton-Easton and Eichelberger 1995; Legge and 
Braciale 2003).  By contrast, while both cDCs and B cells obtained from the medLNs of 
RV6-infected HACII mice (which present the HA self-Ag) could induce division of the 
Treg cells, only the cDCs induced CXCR3 upregulation.  As noted above, B cells are the 
major population of APCs in the medLNs, and 6.5+ Treg cells transferred into intact RV6-
infected HACII mice showed a similar pattern of division with limited CXCR3 
upregulation as was seen during co-culture of 6.5+ Treg cells with B cells (Fig. 4-12 B).  
Furthermore, we observed that when TS1xHA28 LN cells were cultured with equal 
numbers of different APCs isolated from the spleen of an RV6-infected HACII mouse, a 
higher percentage of CD4+ cells expressed Foxp3 after culture with B cells than with 
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other APC subsets, suggesting that B cells may be more capable of inducing expansion 
and/or survival of Treg cells than other APCs (Fig. 4-13).  Thus, presentation of the self 
HA by B cells in HACII mice can induce selective expansion of Treg cells without 
prompting CXCR3 upregulation, thereby enlarging the CXCR3- Treg cell pool and 
potentially limiting the formation of Treg cells that could efficiently traffic to the lungs of 
infected mice.   
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4.3  Summary of Results and Discussion 
 
4.3.1  Treg cells present at infection sites expand from pre-existing Treg cells  
 
 One potential source of Treg cells that accumulate at infection sites is pTreg cells 
that differentiate from CD4+Foxp3- cells upon recognition of pathogen-derived Ag.  
However, we found that 6.5+CD4+Foxp3- cells divided extensively during infection with 
PR8 virus, but did not upregulate Foxp3 (Fig. 4-2.  This result is reminiscent of a 
previous study in which CD4+Foxp3- T cells expressing a transgenic TCR specific for M. 
tuberculosis also did not differentiate into Foxp3+ Treg cells during M. tuberculosis 
infection (Shafiani et al. 2010).  Moreover, Treg cells isolated from the sites of 
Leishmania major or M. tuberculosis infection were found to expand from a pre-existing 
pool of polyclonal Treg cells, while a congenically-marked population of polyclonal T 
cells that did not express either CD25 or Foxp3 did not upregulate these molecules 
during infection (Belkaid et al. 2002; Shafiani et al. 2010).  Thus, these studies 
collectively provide evidence that Treg cells that accumulate during infection expand 
from pre-existing Treg cells, and do not convert from CD4+Foxp3- cells. 
 
4.3.2  Treg cells differentiated and suppressed the anti-viral immune response 
more efficiently when cognate Ag was derived from virus than from self 
 
To assess whether recognition of self-HA could drive 6.5+ Treg cell activity during 
influenza virus infection, 6.5+ Treg cell accumulation and differentiation in RV6 virus-
infected HA28 mice was compared with 6.5+ Treg cell activity in BALB/c mice infected 
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with RV6 virus, where self-HA is not present.  6.5+ Treg cells underwent very little 
division in the medLNs of RV6 virus-infected BALB/c mice and failed to accumulate 
within the lungs, while 6.5+ Treg cells in PR8 virus-infected BALB/c mice proliferated 
extensively and accumulated in the lungs in large numbers; 6.5+ Treg cells in HA28 mice 
underwent relatively low levels of division in response to the self-HA in these mice, and 
RV6 virus infection did not induce more extensive division or accumulation in the lungs 
in HA28 mice than in BALB/c mice (Fig. 4-3).  Moreover, consistent with our previous 
report, activation of 6.5+ Treg cells was associated with significant upregulation of both 
CXCR3 and T-bet in the medLNs, followed by an accumulation of 6.5+CXCR3+T-bet+ 
Treg cells in the lungs of PR8-infected BALB/c mice and suppression of the lung effector 
T cell response (Bedoya et al. 2013).  By contrast, significantly lower levels of CXCR3 
and T-bet were found in the 6.5+CD4+Foxp3+ Treg cells in the medLNs of RV6-infected 
HA28 or BALB/c mice, few of these cells accumulated in the lungs, and the effector T 
cell responses were not significantly affected (Fig. 4-4 and Fig. 4-5).  Thus, even though 
interactions with the self-HA as it is presented in HA28 mice can promote the formation 
and persistence of 6.5+CD4+Foxp3+ Treg cell both intrathymically and in the periphery, 
reactivity with this self-peptide was unable to induce activation of the Foxp3+ Treg cells 
sufficiently to allow them to modulate an acute influenza virus infection.  In contrast, a 
similar number of Treg cells with identical specificity could modulate anti-viral immunity 
when cognate Ag was present as a viral Ag.   
 
It was possible that the 6.5+ Treg cells failed to differentiate efficiently and 
modulate anti-influenza virus immunity in response to recognition of the HA self-peptide 
in HA28 mice because the level of TCR stimulation they received was much lower than 
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when HA was present as a PR8 virus-derived Ag, as evidenced by the differences in 
6.5+ Treg cell proliferation in these two environments.  To determine whether increasing 
the stimulatory potency of the self-Ag might induce 6.5+ Treg cell activity during RV6 
virus infection, we transferred 6.5+Ly5.1+ Treg cells into HACII mice.  Transferred 6.5+ 
Treg cells proliferated more in an HACII host than in an HA28 host, and the extent of 
proliferation closely resembled that in a PR8-infected BALB/c mouse, but very few Treg 
cells accumulated in the medLNs of uninfected HACII mice, and no upregulation of 
CXCR3 or T-bet occurred (Fig. 4-6 and 4-7).  When the HACII recipient mice were also 
infected with the weakly crossreactive RV6 virus, the Ly5.1+ Treg cells accumulated in 
increased numbers in the medLNs, although the percentage of CD4+ cells that were 
donor-derived did not increase, suggesting that Ly5.1+ Treg cells were not being 
specifically recruited to the medLN as a result of infection.  Additionally, a subset of 
Ly5.1+ Treg cells upregulated CXCR3 and T-bet and trafficked to the lungs.  Based on 
previous studies using IFN-γR-/- Treg cells, it is likely that the high levels of IFN-γ 
induced by the RV6 virus infection promoted this CXCR3 upregulation, which coupled 
with TCR stimulation by the self-HA, was able to promote the formation of 6.5+T-
bet+Foxp3+ Treg cells in HACII mice (Koch et al. 2009).  However, this process occurred 
with significantly lower efficiency in RV6 virus-infected HACII mice than in PR8-infected 
BALB/c mice, and 6.5+ Treg cells did not significantly impair the anti-viral effector 
response in the lungs of RV6 virus-infected mice.  Thus, in two different mouse lineages 
in which HA was expressed as a self-Ag, either in a weakly immunostimulatory manner 
capable of inducing 6.5+ Treg cell differentiation or in a strongly immunostimulatory form 
in which expression was targeted to APCs, recognition of self-HA induced less efficient 
accumulation at infection sites, differentiation, and modulation of the effector immune 
response than did recognition of virus-derived HA. 
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4.3.3  Recognition of a strongly stimulatory self-Ag can impair the ability of Treg 
cells to respond upon subsequent recognition of a viral Ag 
 
Unexpectedly, 6.5+ Treg cell recognition of cognate self-HA expressed in a 
strongly immunostimulatory manner in HACII mice actually inhibited the ability of these 
Treg cells to respond to subsequent recognition of viral HA.  A lower percentage of 6.5+ 
Treg cells expressed CXCR3 and T-bet in the medLN of PR8-infected HACII mice than 
PR8-infected BALB/c mice, and many fewer of these cells accumulated in the medLNs 
and lungs of infected HACII mice (Fig. 4-6 and Fig. 4-7).  Furthermore, the limited 
number of 6.5+ Treg cells that did enter the lungs of PR8-infected HACII mice did not 
significantly affect effector T cell accumulation in these mice, despite their ability to 
produce IL-10. 
   
Several phenotypic changes occurred in 6.5+ Treg cells that were adoptively 
transferred into HACII hosts.  Most notably, these cells exhibited decreased expression 
of Foxp3, CD25, and the 6.5 TCR and increased expression of PD-1 relative to 6.5+ Treg 
cells isolated from a PR8 virus-infected BALB/c mouse (Fig. 4-8).  Treg cells that lose 
Foxp3 expression also lose their ability to suppress, and Treg cells from CD25-/- mice fail 
to expand or to prevent autoimmune lymphoproliferative disease (Furtado et al. 2002; 
Williams and Rudensky 2007).  Thus, it is possible that downmodulation of CD25 and/or 
Foxp3 renders 6.5+ Treg cells adoptively transferred into HACII mice less suppressive.  
Downregulation of CD25 and Foxp3 by 6.5+ Treg cells in HACII hosts occurred to a 
lesser extent during influenza virus infection than in an uninfected host, which is 
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somewhat surprising given reports that ongoing inflammation can cause loss of Foxp3 in 
Treg cells (Laurence et al. 2012; Zhou et al. 2009).  However, we have previously shown 
that IL-2 is increased in the serum of PR8 virus-infected BALB/c mice (Bedoya et al. 
2013), and IL-2 signaling can increase levels of CD25 and Foxp3 expression on Treg 
cells, providing a potential explanation for their increased stability in the presence of 
infection (Fontenot et al. 2005).  Downmodulation of the TCR could render 6.5+ Treg 
cells less responsive to antigenic stimulation, making them less able to mediate 
suppression or to continue proliferating once they have been activated and trafficked to 
the lungs (Schonrich et al. 1991).  Finally, high levels of PD-1 expression could 
potentially reduce Treg cell the suppressive capabilities of Treg cells and/or limit their 
accumulation, as has been shown for Foxp3+ follicular regulatory T cells (Sage et al. 
2013).  
 
The failure of 6.5+ Treg cells to efficiently upregulate expression of T-bet and 
CXCR3 during influenza virus infection in HACII mice could also affect their ability to 
modulate the immune response, as CXCR3 has been shown to direct CD4+ T cell 
trafficking into infected lungs (Kohlmeier et al. 2009).  We found that 6.5+ Treg cells that 
were transferred into HACII mice at day 4 post-infection upregulated CXCR3 more 
efficiently than did 6.5+ Treg cells adoptively transferred into HACII mice one day prior to 
infection (Fig. 4-9).  Furthermore, a higher percentage of 6.5+ Treg cells in the medLNs 
than in the spleens of RV6 virus-infected HACII mice had upregulated CXCR3.  These 
data suggest that the surrounding inflammatory milieu at the time of initial encounter with 
cognate self-Ag may play a crucial role in determining the differentiative fate of Treg 
cells. 
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4.3.4  6.5+ Treg cells respond differently depending on which APC subset presents 
cognate Ag 
 
 Different APC subsets were isolated from the medLNs and lungs of PR8 virus-
infected BALB/c mice and RV6 virus-infected HACII mice, and cultured with 
6.5+CD4+Foxp3- cells and 6.5+CD4+Foxp3+ cells isolated from the pLNs of TS1xHA28 
mice to assess their ability to drive Treg cell division and differentiation.  B cells isolated 
from the medLNs of RV6 virus-infected HACII mice were able to present self-HA to Treg 
cells in a manner that induced division but not CXCR3 upregulation (Fig. 4-12).  In 
contrast, B cells isolated from the medLNs of PR8 virus-infected BALB/c mice failed to 
induce Treg cell proliferation, which is consistent with a previous study showing that B 
cells present little or no viral Ag in the medLN during influenza virus infection (Hamilton-
Easton and Eichelberger 1995).  Interestingly, DCs from both RV6 virus-infected HACII 
mice and from PR8 virus-infected BALB/c mice, presenting self-HA and virus-derived 
HA, respectively, induced both division and CXCR3 upregulation by Treg cells.  
Furthermore, B cells were the most prevalent APC subset within the medLNs, and could 
support Treg cell expansion/survival more efficiently than the other APCs that we 
examined (Fig. 4-11 and Fig. 4-13).  Together, these data support a model in which 6.5+ 
Treg cells in the medLN of influenza virus-infected HACII mice encounter B cells 
presenting cognate self-Ag with greater regularity than DCs, and interactions with B cells 
induce the expansion of 6.5+ Treg cells that do not express CXCR3.  As a result of this 
failure to differentiate, 6.5+ Treg cells cannot efficiently traffic to the lungs, and therefore 
do not suppress effector cell accumulation in the lungs.    
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CHAPTER 5:  Discussion and Speculation 
 
5.1  Introduction  
 
 Treg cells are required to prevent widespread immune activation and 
autoimmune lymphoproliferative disease, and these cells can also participate in and 
modulate anti-pathogen immune responses (Fontenot, Gavin, Rudensky 2003; Kim, 
Rasmussen, Rudensky 2007; Maizels and Smith 2011; Sakaguchi et al. 1995).  
However, how variations in expression and presentation of cognate Ag can affect the 
ability of Treg cells to undergo activation and differentiation has not been well 
characterized.  We have shown that cognate self-Ag presented in a relatively less 
immunostimulatory manner can induce both reactive thymocytes and CD4+ T cells in the 
periphery to upregulate Foxp3 and differentiate into functional Treg cells, while the same 
self-Ag expressed at higher levels and in different cell types did not drive Treg cell 
formation.  Recognition of the formation-inducing Ag when it was present as a self-Ag 
did not induce Treg cells to enter the lungs and modulate the anti-pathogen immune 
response during influenza virus infection.  Contrarily, recognition of the same Ag when it 
derived from viral protein resulted in Treg cell differentiation and suppression of the anti-
viral immune response.  Moreover, initial recognition of a highly stimulatory form of self-
Ag in the absence of inflammatory cytokines inhibited the ability of Treg cells to respond 
to subsequent recognition of viral Ag.  In this chapter, we discuss how these results 
relate to previous studies describing the signals required for Treg cell formation and 
activity.  
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5.2 Treg cell formation in vivo 
 
 
 TCR-mediated recognition of self-peptide:MHC complexes can induce 
thymocytes to undergo deletion or differentiate into Foxp3+ Treg cells, as has been 
shown using TCR-transgenic mice crossed with mice that express the cognate Ag as 
self (Apostolou et al. 2002; Jordan et al. 2001; Walker et al. 2003).   Evidence suggests 
that the amount of cognate peptide that is present at this stage can be a crucial factor in 
determining the fate of autoreactive thymocytes: relatively higher doses of cognate 
peptide lead to more extensive deletion, whereas lower doses induce less deletion and 
greater accumulation of CD4+Foxp3+ Treg cells (Atibalentja, Byersdorfer, Unanue 2009; 
Picca et al. 2009).  Our results are in agreement with these published observations, as 
we found that recognition of self-HA drove extensive deletion of 6.5+CD4SP thymocytes 
in TS1xHACII mice, and very little Foxp3 expression in 6.5+CD4SP thymocytes and 
6.5+CD4+ T cells was observed (Fig. 3-2).  In contrast, in TS1xHA28 mice, in which the 
self-HA was expressed at much lower levels in both the thymus and peripheral tissues, 
deletion of 6.5+CD4SP thymocytes occurred, but at much lower levels than in the 
TS1xHACII mouse.  Moreover, more 6.5+CD4+Foxp3+ cells accumulated in the thymus 
and pLNs of TS1xHA28 mice than TS1 or TS1xHACII mice.  Previous studies have 
shown that activation of the PI3K/Akt/mTOR pathway downstream of the TCR limits 
Foxp3 upregulation both in vitro and in the thymus, while blockade of this pathway 
increased Treg cell induction (Haxhinasto, Mathis, Benoist 2008; Sauer et al. 2008).  
Thus, increased activation of this pathway in 6.5+ thymocytes in TS1xHACII mice where 
cognate HA is expressed at higher levels likely contributes to the paucity of 
6.5+CD4SPFoxp3+ thymocytes in these mice.   
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 The current 2-step model of Treg cell formation posits that CD4SP thymocytes 
first upregulate CD25 upon TCR stimulation, then upregulate Foxp3 after exposure to IL-
2 (Lio and Hsieh 2008).  However, we observed a substantial population of 6.5+CD4SP 
thymocytes in TS1xHA28 mice that had upregulated Foxp3, but not CD25 (Fig. 3-3 A).  
Recognition of self-HA drove Foxp3 upregulation in these cells, as no Foxp3 expression 
on 6.5+CD4SP thymocytes was observed in TS1 mice.  Moreover, the percentage of 
6.5+CD4+Foxp3+ cells expressing CD25 was higher in the pLNs than in the thymus, and 
a similar pattern was observed between CD4SPFoxp3+ thymocytes and CD4+Foxp3+ T 
cells in BALB/c mice with unmanipulated TCR repertoires.  These observations raise 
questions regarding the fate of the CD4SPCD25-Foxp3+ thymocytes because they must 
either upregulate CD25, downregulate Foxp3, or undergo apoptosis, since few 
CD4+CD25-Foxp3+ T cells exist in the periphery.  If they subsequently upregulate CD25, 
this would be in contrast to the established model of Treg cell development.  
Alternatively, Foxp3 expression may be transient and unstable in these 
CD4SPCD25-Foxp3+ thymocytes.  IL-2 signaling enhances expression of both CD25 and 
Foxp3 (Fontenot et al. 2005), and CD4+Foxp3+ cells with low expression of CD25 have 
been found to be less capable of maintaining Foxp3 expression than CD25hiCD4+Foxp3+ 
cells; thus it is possible that in the absence of CD25 expression, CD4SPFoxp3+ 
thymocytes cannot compete for IL-2 and subsequently fail to maintain Foxp3 (Komatsu 
et al. 2009; Komatsu et al. 2014).  We additionally found that the transcription factor 
Helios, which has recently been identified as a marker of strongly autoreactive 
thymocytes (Daley, Hu, Goodnow 2013), was upregulated in the majority of 
6.5+CD4SPFoxp3- thymocytes in TS1xHA28 mice, indicating that they had been exposed 
to self-HA (Fig. 3-3 A).  Previous studies have shown that while some 
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CD4SPHelios+Foxp3- thymocytes undergo Bim-mediated deletion, a subset can survive 
through a Card11-dependent mechanism and remain Foxp3- (Daley, Hu, Goodnow 
2013).  Thus, it is likely that some of the 6.5+CD4+Foxp3- cells in the periphery of 
TS1xHA28 mice encountered cognate Ag during development in the thymus and still 
failed to upregulate Foxp3.  Furthermore, autoreactive Helios+CD4SPFoxp3- thymocytes 
were identified in BALB/c mice (Fig. 3-3 B), confirming that this population of 
autoreactive CD4SP thymocytes does not form solely as a consequence of the TCR 
transgene, and raising the question as to whether these cells are able to enter the 
periphery as Ag-experienced autoreactive CD4+Foxp3- T cells.  
 
Thymically-derived Treg (tTreg) cells appear to constitute the majority of the Treg 
cell population (Hsieh et al. 2006; Josefowicz et al. 2012), but in certain circumstances 
CD4+Foxp3- cells in the periphery can differentiate into Foxp3+ pTreg upon recognition of 
cognate Ag (Yadav, Stephan, Bluestone 2013).  Most of the work establishing that Treg 
cells can differentiate in the periphery from CD4+Foxp3- cells following recognition of Ag 
has been done using either exogenous administration of a cognate Ag (through injection 
or feeding) or in a lymphopenic environment (Coombes et al. 2007; Gottschalk, Corse, 
Allison 2010; Knoechel et al. 2005; Kretschmer et al. 2005; Lathrop et al. 2008; Sun et 
al. 2007).  However, exogenously administered antigens are subject to clearance and 
turnover, and the extent to which specificity for a naturally processed, continuously 
present self-Ag under steady-state conditions might also drive pTreg cell formation, and 
the conditions under which this may occur, are still being determined.  Given that 
self-Ags exist in abundance and can be expressed at varying levels and by many 
different cell types, we were interested in how varying the presentation of self-HA might 
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affect the fate of autoreactive 6.5+CD4+Foxp3- T cells.  In HA28 mice, a subset of 
6.5+CD4+CD25-Foxp3- T cells had upregulated Foxp3 expression at day 3 post-transfer, 
but this group was limited to T cells that had undergone relatively few rounds of division 
(Fig. 3-4).  In contrast, 6.5+CD4+CD25-Foxp3- T cells transferred into HACII hosts had all 
divided extensively, and no expression of Foxp3 was observed.  These data are 
consistent with a previous study in which pTreg cells were formed by injection of cognate 
peptide that showed that a low dose of peptide induced more pTreg cell formation than a 
high dose, and that those cells that upregulated Foxp3 had undergone fewer rounds of 
division than those that did not (Gottschalk, Corse, Allison 2010).  One possible 
explanation for these observations is that relatively weaker activation of TCR signaling 
(such as occurs in HA28 mice) is more conducive to Treg cell formation than relatively 
strong TCR signaling.  In support of this theory, there is evidence to suggest that a 
strong TCR signal is detrimental to Treg cell formation, as activation of the 
PI3K/Akt/mTOR pathway downstream of the TCR has been shown to limit Foxp3 
upregulation both in vitro and in the thymus, while blockade of this pathway increased 
Treg cell induction (Haxhinasto, Mathis, Benoist 2008; Sauer et al. 2008).  Additionally, a 
strong TCR signal abrogated Treg cell induction in vitro in response to TGF-β through 
NF-κB-dependent production of inflammatory cytokines (Molinero et al. 2011).  However, 
if TCR signal strength is the sole determinant of pTreg cell formation, this would 
necessitate that some 6.5+ T cells in HA28 mice receive a relatively weak signal from the 
HA (becoming Foxp3+ and undergoing limited division), while other cells receive a 
stronger signal from the HA self-peptide. Competition for Ag could limit exposure to 
cognate peptide:MHC complexes such that some cells receive a stronger TCR signal 
than others, and indeed intraclonal competition for Ag has been shown to occur within 
the thymus, although in this case, competition for Ag limited the niche size for Treg cells 
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and reduced the percentage of clonotypic cells that upregulated Foxp3 (Bautista et al. 
2009).  Alternatively, intrinsic factors, such as epigenetic differences, may dictate which 
CD4+Foxp3- cells upregulate Foxp3 in an HA28 mouse, and the fact that the Foxp3+ 
cells have undergone relatively fewer rounds of division could be a consequence of the 
ability of Foxp3 to interact with downstream targets and induce a relatively non-
proliferative (or “anergic”) state in those cells.  Evidence in support of this possibility 
comes from studies showing that retroviral transduction of Foxp3 into naïve CD4+ T cells 
resulted in less robust proliferation upon TCR stimulation with anti-CD3 mAb compared 
with cells transduced with a control retrovirus  (Hori, Nomura, Sakaguchi 2003), and 
from our own observations that 6.5+CD4+Foxp3- cells underwent more rounds of division 
than naturally-occurring 6.5+CD4+Foxp3+ cells after transfer into HA28 recipients. 
 
Ultimately, nearly half of the donor-derived cells in HA28 recipients expressed 
Foxp3 at days 14 and 21 post-transfer of 6.5+CD4+CD25-Foxp3-Ly5.1+ cells isolated 
from TS1.Foxp3eGFP.Ly5.1 mice (Fig. 3-6).  The numbers of Ly5.1+ cells recovered were 
declining at these time points, suggesting that acquired Foxp3 expression was relatively 
stable in these pTreg cells and that 6.5+CD4+ T cells that had undergone division without 
upregulating Foxp3 were gradually deleted, as has been observed in some other 
adoptive transfer settings (Walker et al. 2003).  This stable expression of Foxp3 
contrasts some findings in human and mouse systems in which Foxp3 was found to be 
transiently expressed by CD4+ T cells at early stages following activation, but was not 
indicative of Treg cell development (Miyao et al. 2012; Wang et al. 2007).  6.5+ pTreg 
cells that formed in HA28 mice upregulated expression of CD25 and Helios, and lost the 
ability to produce IFN-γ and IL-2.  When we re-isolated Treg cells generated in the 
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periphery of an HA28 mouse at day 7 post-transfer, we found that they were able to 
suppress 6.5+Foxp3- T cell division in vitro to a similar extent as thymically-generated 
Treg cells of the same specificity.  However, while nearly all of the tTreg cells maintained 
Foxp3 expression after 4 days of in vitro culture, some of the pTreg cells began to lose 
Foxp3 expression.  Foxp3 expression is stabilized by demethylation of the conserved 
non-coding DNA sequence 2 (CNS2) of the Foxp3 locus, a Treg cell-specific 
demethylated region (TSDR) that is normally methylated in CD4+Foxp3- Treg cells 
(Ohkura, Kitagawa, Sakaguchi 2013), and CNS2 deficiency results in loss of heritable 
Foxp3 expression (Feng et al. 2014; Zheng et al. 2010).  While in vitro generated Treg 
cells failed to completely demethylate CNS2, which is consistent with their unstable 
Foxp3 expression (Floess et al. 2007; Miyao et al. 2012), pTreg cells formed in vivo can 
achieve demethylation of the Foxp3 locus under some conditions (Ohkura et al. 2012; 
Polansky et al. 2008).  It is possible that complete CNS2 demethylation had not occurred 
in 6.5+CD4+Foxp3+ pTreg cells at day 7 post-transfer into HA28 hosts, potentially 
explaining their lack of stability of this time point.  Further experiments would be needed 
to determine whether hypomethylation of TSDRs, including CNS2, occurred in the 6.5+ 
pTreg cells generated in HA28 mice, and the time period over which this demethylation 
might take place.  In contrast to the relatively stable Foxp3 expression in a subset of 
6.5+CD4+ pTreg cells formed in HA28 mice, we suspect that transient upregulation of 
Foxp3 may occur in 6.5+CD25-Foxp3- cells after transfer into HACII hosts.  Although we 
were never able to observe Foxp3 expression in donor-derived cells this setting, we 
failed to obtain consistent engraftment unless the recipient HACII mice also expressed a 
Foxp3eGFP allele (Fig. 3-5).  Additional studies would be required to confirm this 
conclusion, but this observation provides indirect evidence that these cells might 
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transiently express Foxp3, and concurrent expression of the GFP reporter transgene 
may mediate rejection in recipient mice that do not induce tolerance to GFP.   
 
We looked for evidence of 6.5+CD4+ T cell deletion in HACII recipients, as 
previous studies have shown that exogenous administration of minor lymphocyte 
stimulating (Mls) superantigen or staphylococcal enterotoxin A superantigen resulted in 
deletion of superantigen-reactive T cells in the periphery, but acute deletion of 6.5+CD4+ 
T cells did not occur (McCormack et al. 1993; Webb, Morris, Sprent 1990).  However, we 
did find that 6.5+CD4+Foxp3- cells were less capable of producing IL-2 and IFN-γ at day 
14 post-transfer in HACII hosts than HA28 hosts, despite undergoing more extensive 
proliferation in the HACII hosts (Fig. 3-7).  Thus, recognition of a relatively weakly 
immunostimulatory self-Ag can induce pTreg cell differentiation, but reactive CD4+ T 
cells that remained Foxp3- retained the ability to produce IL-2 and IFN-γ.  In contrast, the 
same self-Ag presented in a more immunostimulatory manner failed to drive pTreg 
formation, but significantly fewer of the transferred CD4+Foxp3- cells were capable of 
producing IL-2 and IFN-γ after two weeks in vivo.  It is possible that 6.5+CD4+Foxp3- T 
cells transferred into HACII mice differentiate towards a different CD4+ helper T cell 
phenotype, but we did not see evidence of IL-17 production, such that it is unlikely that 
they are becoming Th17 cells.  Alternatively, there have been descriptions of both CD4+ 
T cell anergy and exhaustion following an initial TCR stimulation and strong proliferative 
response, both of which are characterized by a loss of ability to divide and produce 
cytokine upon subsequent TCR engagement (Crawford et al. 2014; Lanoue et al. 1997; 
Tanchot et al. 2001).  Further studies would be necessary to determine whether 
6.5+CD4+Foxp3- cells transferred into HACII mice may be adopting one of these fates, 
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and to assess whether these cells develop an impaired proliferative response to 
subsequent TCR stimulation.  The fact that the number of donor-derived T cells begins 
to decline after day 14 in HACII hosts suggests that they may no longer be dividing at 
the same high rate as when they were first transferred.  It is perhaps somewhat 
surprising that 6.5+CD4+Foxp3+ T cells transferred into HACII were not rapidly deleted 
and did not completely lose the ability to produce IL-2; a previous report determined that 
the majority of 6.5+CD4+ T cells transferred into a different HA-transgenic mouse lineage, 
in which the HA transgene is under control of the Igκ promoter and enhancer elements, 
were deleted within 14 days of transfer after an initial expansion period, and those that 
did not undergo deletion became anergic (Lanoue et al. 1997).  However, in a separate 
study, pigeon cytochrome c (PCC)-reactive CD4+ T cells transferred into T cell-deficient 
mice that expressed PCC as a self-Ag under control of an MHCI promoter expanded and 
adopted an anergic phenotype, but no deletion was observed (Tanchot et al. 2001).  In 
this instance, anergy was characterized by reduced division and decreased production 
of IL-2 and IFN-γ upon subsequent stimulation with PCC peptide in vitro relative to PCC-
reactive CD4+ T cells transferred into mice that lacked the PCC transgene (Tanchot et 
al. 2001).  However, PCC-reactive CD4+ T cells re-isolated from PCC transgenic mice 
could produce some IL-2 and IFN-γ following stimulation with a high concentration of 
PCC peptide (Tanchot et al. 2001).  It is possible that differences in the relative amount 
of cognate self-Ag or in the cell type on which it is expressed may determine the extent 
to which deletion occurs.  For instance, in HACII mice, HA is expressed and presented 
by DCs, which may support 6.5+CD4+Foxp3- T cell persistence, and the high level of 
expression may continue to induce some cytokine production.    
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It was noteworthy that the 6.5+CD4+Foxp3+ pTreg cells that were isolated from 
the pLNs of HA28 mice also acquired expression of Helios, the levels of which increased 
progressively following transfer, either through selection of Helios+ cells or gradual 
upregulation of the molecule itself, such that by days 14 and 21 post-transfer the large 
majority of these cells were Helios+ (Fig. 3-8).  This pattern of upregulation was different 
than what was seen using injected Ag, as in that case Helios was upregulated prior to 
Foxp3, and thus all Foxp3+ pTreg cells initially expressed Helios (Gottschalk, Corse, 
Allison 2012).  In both studies, Helios was upregulated in a subset of Foxp3- cells, but by 
day 21 post-initial antigenic exposure, only Foxp3+ cells expressed Helios.   Additionally, 
Gottschalk, et al. observed a subsequent decline in Helios levels among the Foxp3+ 
pTreg cells that could be reversed by administering a second dose of peptide.  We did 
not detect any similar decrease in Helios levels, likely because pTreg cells continue to 
receive continuous low-level TCR signal from recognition of a self-Ag.   
 
Since Helios was not upregulated in Ag-specific Treg cells formed in vitro or in 
vivo by Ag feeding, it was initially suggested that Helios was a marker for Treg cells that 
had formed within the thymus (Thornton et al. 2010).  This conclusion was challenged by 
subsequent studies showing that pTreg cells that developed following i.v. injection of 
cognate Ag did express Helios, and it was unclear whether differences in the route of Ag 
administration might be causing these differences in Helios expression (Gottschalk, 
Corse, Allison 2012).  Consistent with this possibility, we found that a significantly higher 
percentage of the 6.5+CD4+Foxp3+ pTreg cells isolated from the medLNs of HA28 mice 
were Helios- than was the case for those isolated from non-gut-draining pLNs (Fig. 3-9).  
It is tempting to speculate that the presence of distinct APC populations and/or 
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differences in the cytokine environment in non-gut draining versus gut-draining LNs may 
promote these differences in Helios expression.  For example, specialized CD103+ DCs 
that reside in the gut and mesenteric LN and that can induce Treg cell differentiation via 
a TGF-β- and retinoic acid-dependent mechanism may be responsible for the 
development of Helios- pTreg cells (Coombes et al. 2007; Sun et al. 2007), while a 
separate APC population in non-gut draining LNs may drive both Foxp3 and Helios 
upregulation.  Alternatively, elevated levels of TGF-β in the gut-draining mesLNs may 
promote their formation, since “induced” Foxp3+ Treg cells that are generated by 
activation of conventional CD4+ T cells in the presence of TGF-β also lack Helios 
expression (Thornton et al. 2010).  Whatever the mechanism, these findings 
demonstrate that pTreg cells with identical specificity for a self-Ag and formed in the 
same mouse can express different amounts of Helios according to the anatomical 
location from which they are isolated. 
 
If recognition of self-Ag can drive Treg cell formation in both the thymus and the 
periphery, then one may wonder why all T cells with a TCR specificity that allows 
recognition of self-Ag, and that escape deletion, do not ultimately develop into Foxp3+ 
Treg cells.  The fact that this does not occur is evidenced by the coexistence of Foxp3+ 
and Foxp3- 6.5+ T cells in the periphery of TS1xHA28 mice (Picca et al. 2009) and of 
CD25- and CD25+ T cells expressing a TCR specific for OVA in mice co-expressing OVA 
as a neo-autoantigen (Walker et al. 2003).  Furthermore, some overlap has been found 
to occur in the TCR repertoire of naturally-occurring autoreactive Foxp3+ and Foxp3- T 
cells (Hsieh et al. 2006), suggesting that CD4+Foxp3- cells can recognize the same 
antigens as autoreactive CD4+Foxp3+ cells.  Finally, depletion of Treg cells with 
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diphtheria toxin (DT) in Foxp3-DT receptor mice results in fatal autoaggressive 
lymphproliferatvie disease (Kim, Rasmussen, Rudensky 2007), which implies that 
autoreactive cells exist in steady-state, but are normally restrained by the presence of 
Treg cells.  One possible explanation for why not all autoreactive T cells that escape 
thymic deletion ultimately develop into Treg cells is that there is an intrinsic difference in 
the cells themselves.  However, 6.5+CD25-Foxp3- T cells that developed in TS1xHA28 
mice in the presence of cognate-autoantigen were no less capable of upregulating 
Foxp3 following transfer into HA28 hosts than were naïve 6.5+CD25-Foxp3- T cells 
isolated from TS1 mice (Fig. 3-11).  In fact, the Ag-experienced cells may have been 
primed to upregulate Foxp3, as the percentage expressing Foxp3 was slightly higher at 
day 3 post-transfer than among previously naïve T cells.  Demethylation of TSDRs, 
including at the Foxp3 locus, can occur in a TCR stimulation-dependent manner in the 
absence of Foxp3 expression (Ohkura et al. 2012), and it would be interesting to know 
whether 6.5+CD4+Foxp3- cells in TS1xHA28 mice exhibit a Treg cell-specific 
demethylation pattern.  A second possibility is that a Treg cell niche exists that limits the 
accumulation of Treg cells of a defined TCR specificity.  Within the thymus, it was found 
that the number of thymocytes expressing a transgenic TCR that could develop into 
Foxp3+ Treg cells was limited, and that decreasing the clonal frequency of TCR-
transgenic thymocytes resulted in an increased percentage of these cells expressing 
Foxp3 (Bautista et al. 2009; Leung, Shen, Lafaille 2009).  The authors of these studies 
posit that competition for Ag may define the size of the Treg cell niche.  Interestingly, in 
our studies, the percentage of 6.5+ T cells expressing Foxp3 in a TS1xHA28 mouse was 
similar to that in an HA28 mouse at days 14 and 21 post-transfer of 6.5+CD4+CD25-
Foxp3- cells, despite the fact that the frequency of clonotypic cells was much higher in a 
TS1xHA28 mouse than in the adoptive transfer experiments.  Although we do not know 
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for certain whether this percentage remains consistent beyond day 21 post-transfer, it is 
interesting to speculate that the Treg niche in this case may be defined as a percentage 
of T cells of a given specificity rather than as an absolute number.  Furthermore, 
6.5+CD4+CD25-Foxp3- T cells transferred into a TS1xHA28 mouse failed to upregulate 
Foxp3, perhaps indicating that the 6.5+ Treg cell niche is already full in these mice (Fig. 
3-12 C).  Thus, Ag may not be limiting in a setting where it is expressed in a systemic 
and persistent manner, but another limiting factor, such as IL-2 may restrict the 
formation of Treg cells.  IL-2 is required for Treg cell formation, expansion and 
homeostasis (Nelson 2004), and one group found that the accumulation of CD4+CD25+ 
Treg cells in a mouse correlated with the number of CD4+ T cells capable of producing 
IL-2 that were present (Almeida, Zaragoza, Freitas 2006).  Thus, it is possible that some 
equilibrium may develop between IL-2-producing autoreactive CD4+Foxp3- T cells and 
IL-2-consuming autoreactive CD4+Foxp3+ Treg cells of the same specificity.  
Administration of IL-2:anti-IL-2 complexes can selectively expand Treg cells (Webster et 
al. 2009), and it would be interesting to know whether the percentage of 6.5+ T cells 
expressing Foxp3 would change in a TS1xHA28 mouse or in an HA28 mouse in an 
adoptive transfer setting upon provision of exogenous IL-2. 
 
Our studies have shown that recognition of self-Ag can drive CD4+Foxp3- T cells 
in the periphery to upregulate Foxp3, CD25, and Helios, and to differentiate into 
functionally suppressive Treg cells.  However, the extent to which this actually occurs in 
vivo and its relative importance in maintaining self-tolerance remains unclear.  Thus far, 
no reliable marker has been found to differentiate tTreg cells and pTreg cells, making it 
difficult to determine the extent to which each subset contributes to the overall Treg cell 
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pool and to maintaining immune homeostasis in different circumstances.  Helios and 
Neuropilin-1 have been suggested to be expressed exclusively by tTreg cells, but Helios 
can be upregulated on pTreg cells generated in pLNs, and Neuropilin-1 can be 
upregulated by Neuropilin-1-CD4+Foxp3+ cells in lymphopenic conditions (Gottschalk, 
Corse, Allison 2012; Yadav et al. 2012).  pTreg cells can differentiate following 
recognition of food Ag or commensal bacteria, and likely play a role in preventing 
inflammation in response to innocuous antigens at mucosal barriers (Coombes et al. 
2007; Fontenot et al. 2005; Lathrop et al. 2011; Sun et al. 2007).  Mice that lack the 
intronic Foxp3 element CNS1 exhibit normal Treg cell development in the thymus, but 
impaired Foxp3 induction in CD4+ T cells following stimulation with anti-CD3 and TGF-β 
in vitro or feeding with cognate Ag in vivo (Josefowicz et al. 2012; Zheng et al. 2010).  
Furthermore, CNS1-/- mice have fewer Foxp3+ cells in the intestines and gut-associated 
lymphoid tissue, and develop inflammation in the gastrointestinal tract and lungs, 
suggesting that the ability of CD4+Foxp3- T cells to upregulate Foxp3 in response to 
TGF-β is critical to preventing inflammation at mucosal sites (Josefowicz et al. 2012; 
Zheng et al. 2010).  However, while TGF-β is crucial for Foxp3 induction in vitro and in 
the gut, it may not be necessary for pTreg cell differentiation in non-gut draining LNs 
(Chen et al. 2003; Schlenner et al. 2012).  Thus, these studies provide evidence that 
pTreg cells can be important in preventing pathological responses to commensals and 
innocuous antigens at mucosal surfaces, but do not necessarily address whether 
autoreactive pTreg cells may be important in maintaining self-tolerance.  An additional 
study explored the relative importance of pTreg cells and tTreg cells in maintaining 
immune homeostasis through adoptive transfer of CD4+ T cells into newborn Foxp3-
deficient mice.  They found that less inflammation occurred when CD4+Foxp3- cells and 
CD4+Foxp3+ were transferred concurrently than when CD4+Foxp3+ T cells were 
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transferred alone, but CD4+Foxp3- T cells were only beneficial when they were capable 
of upregulating Foxp3 and not when they were Foxp3-deficient (Haribhai et al. 2011).  
Additionally, when the transferred CD4+Foxp3- cells contained a Foxp3-DTR reporter 
gene, depletion of pTreg cells that developed by administration of DT resulted in 
increased activation and IFN-γ production by host CD4+ T cells, as well as inflammation 
in the lungs, colon, small intestine and liver.  These data suggest that pTreg cells are 
necessary to reduce systemic inflammation and to limit immunopathology at barrier 
surfaces, although they come with the caveat that in adoptively transferring a limited 
number of tTreg cells into Foxp3-deficient mice, certain TCR specificities could be 
lacking from the tTreg cell pool that pTreg cells can, but perhaps normally would not, 
replace.  
 
5.3 Signals driving Treg cell activity and differentiation during an infection 
 
 Treg cells have been found to suppress the anti-pathogen effector response in a 
multitude of infection models, but how TCR specificity for pathogen-derived and/or self-
peptides can direct this activity is not well understood (Maizels and Smith 2011).  There 
are two potential sources for the Treg cells that accumulate during an infection: (1) 
circulating CD4+Foxp3- cells differentiate into CD4+Foxp3+ cells upon recognition of 
pathogen-derived Ag, or (2) Treg cells at infection sites expand from pre-existing Treg 
cells.  We found that 6.5+CD4+Foxp3- T cells that can recognize the HA molecule of PR8 
influenza virus proliferated heavily during PR8 virus infection, but did not increase Foxp3 
expression (Fig. 4-2).  Similarly, in L. major and M. tuberculosis infection, no conversion 
of conventional CD4+ T cells into Foxp3+ Treg cells was found to occur, and Treg cells at 
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sites of infection expanded from pre-existing Treg cells (Shafiani et al. 2010; Suffia et al. 
2006).  It is possible that the amount of cognate Ag present in an infection may be too 
high and provide too strong of a TCR signal for pTreg cell differentiation to occur.  As 
discussed in the previous section and shown by several different studies, a strong TCR 
signal can be detrimental to Treg cell differentiation (Haxhinasto, Mathis, Benoist 2008; 
Molinero et al. 2011).  Certainly, the amount of proliferation undergone by 
6.5+CD4+Foxp3- cells during PR8 virus infection was more similar to what occurred in 
HACII mice, in which 6.5+ pTreg cell differentiation did not occur, than in HA28 mice.  
Furthermore, an ongoing inflammatory response can be detrimental to pTreg cell 
differentiation (Caretto et al. 2010; Oldenhove et al. 2009).  For instance, the presence 
of a lethal Toxplasma gondii infection in the gut resulted in a decrease in the percentage 
of TCR transgenic T cells that upregulated Foxp3 when cognate Ag was fed to host 
mice, and the presence of IFN-γ inhibited Treg cell development in vitro (Caretto et al. 
2010; Oldenhove et al. 2009).  Thus, Treg cells that accumulate during infection likely do 
not derive from the conversion of CD4+Foxp3- cells during infection, but rather expand 
from Treg cells already present in the pre-immune repertoire.   
 
Studies from our lab had previously shown that 6.5+ Treg cells from TS1xHA28 
mice, which are formed on self-Ag and are capable of recognizing an HA Ag derived 
from PR8 influenza virus, suppressed the anti-viral immune response during PR8 virus 
infection (Bedoya et al. 2013).  Similarly, Treg cells expressing a transgenic TCR 
specific for M. tuberculosis were found to delay the accumulation of pathogen-specific 
CD4+ and CD8+ T cells in the lungs during M. tuberculosis infection (Shafiani et al. 
2010), providing further evidence that pathogen-reactive Treg cells can modify the anti-
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pathogen immune response.  However, many studies have shown that Treg cells are 
predominantly formed based on specificity for self-Ag, leading us to question whether 
Treg cells might also be able to modulate an anti-pathogen immune response as a 
consequence of recognition of self-Ag within the inflammatory environment formed 
during infection (Apostolou et al. 2002; Hsieh et al. 2004; Jordan et al. 2001; Walker et 
al. 2003).  Studies both in vitro and in vivo have shown that Treg cells require a TCR 
signal to be activated, but that they are able subsequently to suppress effector T cells 
with other specificities (Thornton and Shevach 1998; Yu et al. 2005), although this 
remains a matter of some debate (Huang, Zhu, Yang 2005; Tanchot et al. 2004).  To 
determine whether activation on self-HA could induce 6.5+ Treg cells to modulate the 
anti-influenza effector response, we assessed 6.5+ Treg cell activity in HA transgenic 
mice during infection with RV6 virus, with which the 6.5 TCR has limited reactivity.  In 
both HA28 mice, in which 6.5+ Treg cells naturally form, and HACII mice, which express 
a potently stimulatory form of self-HA that induces similar division of 6.5+ Treg cells as 
occurs during PR8 virus infection, 6.5+ Treg cells failed to modulate the anti-viral 
immune response (Fig. 4-5 and Fig. 4-7).  In contrast, recognition of HA derived from 
PR8 virus drove 6.5+ Treg cells to suppress the effector T cell response in a PR8 virus-
infected BALB/c mouse.  Additionally, recognition of viral HA resulted in more 
accumulation in the medLNs and lungs and more upregulation of CXCR3 and T-bet than 
did recognition of self-HA.  Curiously, recognition of self-HA in HACII mice impeded the 
ability of 6.5+ Treg cells to respond to PR8 virus infection, as fewer cells accumulated in 
the medLNs and lungs of PR8 virus-infected HACII mice than PR8 virus-infected BALB/c 
mice (Fig. 4-6).  Furthermore, 6.5+ Treg cells in HACII mice displayed less upregulation 
of T-bet and CXCR3 during PR8 virus infection than in BALB/c hosts, and did not 
significantly affect effector T cell accumulation in the lungs (Fig. 4-7).  Several 
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mechanisms likely contribute to the ability of the HA self peptide to inhibit 6.5+ Treg cell 
differentiation and suppression of the anti-viral immune response in HACII mice.  First, 
we found that 6.5+ Treg cells transferred into HACII mice decreased expression of 
Foxp3, CD25, and the 6.5 TCR, and expressed higher levels of PD-1 than did 6.5+ Treg 
cells isolated from PR8 virus-infected BALB/c mice (Fig. 4-8).  Foxp3 and CD25 
expression are both necessary for Treg cell persistence and function, and their loss 
could potentially explain the lack of 6.5+ Treg cell activity in HACII mice (Furtado et al. 
2002; Williams and Rudensky 2007).  Perhaps surprisingly, given reports that ongoing 
inflammation can cause loss of Foxp3 in Treg cells (Laurence et al. 2012; Zhou et al. 
2009), downmodulation of CD25 and Foxp3 by 6.5+ Treg cells in HACII hosts was 
somewhat ameliorated during influenza virus infection.  However, exposure to 
inflammation has previously been shown to induce changes in the transcriptional profile 
of Treg cells, including upregulation of CD25 and Foxp3 (Arvey et al. 2014).  This 
observation could potentially result from the increase in IL-2 present during an 
inflammatory response, as IL-2 signaling can stabilize CD25 and Foxp3 expression 
(Fontenot et al. 2005).  Additionally, downmodulation of the TCR complex has been 
shown to occur following TCR stimulation, and can render T cells insensitive to 
subsequent stimulation, which could limit the ability of 6.5+ Treg cells to respond to virus-
derived HA (San Jose et al. 2000; Schonrich et al. 1991).  Finally, expression of PD-1 by 
Foxp3+CD4+ follicular regulatory T cells has been shown to limit their expansion and 
reduce their suppressive ability, and it is possible that the strong upregulation of PD-1 
may have similar effects on 6.5+ Treg cells in HACII mice (Sage et al. 2013).  Studies 
from our lab have previously shown that adoptively transferred 6.5+ Treg cells from 
TS1xHA28 mice are also unable to prevent the development of autoimmune arthritis in 
TS1xHACII mice, although transfer of polyclonal Treg cells can block disease 
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development (Oh et al. 2012).  It is likely that a diverse TCR repertoire is required to 
suppress the effector cells that modulate disease development, but an alternative 
explanation could be that the phenotypic changes that occur in 6.5+ Treg cells following 
recognition of self-HA in HACII mice render them incapable of suppression.    
 
The idea that CD4+ T cells must differentiate to acquire unique characteristics in 
response to specific stimuli in order to effectively control different pathogens is well 
appreciated (Zhu and Paul 2010).  More recently, it has been found that Treg cells must 
also differentiate in order to efficiently suppress effector cells in different circumstances, 
and that Treg cells that are effective in one context may be ineffectual in other 
circumstances.  For example, ablation of IL-10 specifically in Treg cells did not result in 
systemic immune activation, but did lead to the development of colitis and increased 
lung allergic inflammation, suggesting that production of IL-10 is required for Treg cell 
activity at mucosal surfaces, but not for prevention of systemic immune activation 
(Rubtsov et al. 2008).  Furthermore, mice in which T helper cell subset (i.e., Th1, Th2, 
Th17) lineage-defining transcription factors were selectively ablated in Treg cells 
developed immunopathology associated with the respective T helper subset (Campbell 
and Koch 2011).  An important component of Treg cell differentiation is likely the 
acquisition of chemokine receptors that direct Treg cells to traffic to where they are 
needed.  For instance, Treg cells genetically deficient in CCR6 accumulated less 
efficiently than their WT counterparts in the central nervous system during EAE 
(Yamazaki et al. 2008).  Acquisition of CXCR3 expression has been shown to direct 
CD4+ T cell trafficking into infected lungs (Kohlmeier et al. 2009), and the lack of CXCR3 
expression by the majority of 6.5+ Treg cells following activation in the medLN of infected 
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HA28 and HACII mice could explain the paucity of 6.5+ Treg cells in the lungs of these 
mice.  Interestingly, 6.5+ Treg cells were able to limit the accumulation of 
6.5+CD4+Foxp3- cells in HA28 mice (Fig. 3-12), showing that activation on the self-HA in 
these mice can drive 6.5+ Treg cell-mediated suppression in at least one context, and 
providing further evidence that the failure of the self-HA to induce 6.5+ Treg cell 
differentiation may be responsible for their lack of activity in the context of an infection. 
 
Previous studies demonstrated that STAT1 signaling, which occurs downstream 
of inflammatory cytokines such as IL-27 and IFN-γ, is necessary for T-bet and CXCR3 
expression by Treg cells (Koch et al. 2012), and indeed, the inflammatory environment 
to which 6.5+ Treg cells are exposed at the time of initial Ag encounter appears to 
contribute to their differentiation.  CXCR3 upregulation on 6.5+ Treg cells occurred more 
readily within the medLN, where the inflammatory response should be elevated, than the 
spleen of a PR8 virus-infected HACII mouse.  Furthermore, waiting until the 
inflammatory response was established in an influenza virus-infected HACII mouse prior 
to adoptive transfer of 6.5+ Treg cells resulted in an increase in the percentage of 
transferred cells expressing CXCR3 in the medLNs relative to when adoptive transfer 
occurred prior to infection (Fig. 4-9).  These data demonstrate that TCR stimulation and 
exposure to inflammatory cytokine (such as IFN-γ) must occur concurrently, rather than 
sequentially, to induce Treg cell differentiation towards a Th1-like phenotype.  However, 
despite being placed directly into an inflammatory setting, a sizable population of 6.5+ 
Treg cells that underwent division still did not upregulate CXCR3, suggesting that the 
factors governing Treg differentiation may be slightly more complicated than simply TCR 
signal plus the general presence of cytokine.   
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We found that B cells that had been purified from RV6-infected HACII mice 
(presenting HA as a self-peptide) could induce extensive division of 6.5+ Treg cells while 
inducing only limited upregulation of CXCR3, resembling the phenotype that is observed 
when 6.5+ Treg cells are transferred into intact uninfected HACII mice (Fig. 4-12).  This 
weak CXCR3 induction appears to be a property of the presentation of a target Ag by B 
cells, because B cells isolated from the lungs of PR8-infected BALB/c mice (i.e. B cells 
expressing the HA as a viral Ag) similarly induced division of 6.5+ Treg cells with limited 
upregulation of CXCR3.  In contrast, DCs isolated from the medLN of either PR8 virus-
infected BALB/c mice or RV6 virus-infected HACII mice (and thus presenting either viral-
HA or self-HA, respectively) induced both 6.5+ Treg cell division and CXCR3 
upregulation.  Upregulation of CXCR3 appeared slightly more elevated when DCs 
presenting viral Ag were used, which could be explained by the fact that all of these DCs 
had taken up viral Ag, potentially triggering pattern recognition receptors that could 
induce further activation and differentiation of the DCs, while DCs presenting self-Ag in 
an HACII mouse had not necessarily come into direct contact with RV6 virus.  B cells 
and DCs express different constellations of costimulatory molecules, which, in 
conjunction with TCR signaling, may drive Treg cells to unique fates, potentially 
including alternative differentiative fates not investigated here.  Alternatively, DCs and B 
cells may produce different cytokines, or may induce production of different cytokines by 
the 6.5+CD4+Foxp3- T cells also present in the cultures, that could affect Treg cell 
differentiation.  Although serum levels of IFN-γ were similar in mice infected with PR8 or 
RV6 virus, it is possible that the localized concentration of IFN-γ around different APC 
subsets may differ.  B cells are by far the most abundant APC in both uninfected HACII 
mice and in the medLNs of influenza virus-infected mice, and were found to 
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preferentially support the proliferation and accumulation of Treg cells, as has been 
observed previously (Chen and Jensen 2007; Sun et al. 2008).  These findings provide 
evidence that efficient presentation of an Ag by B cells can exert a dominant effect on 
the differentiation of Treg cells even when DCs presenting the same Ag are also 
present.  When we attempted to deplete B cells in HACII mice by treatment with anti-
CD20 antibody prior to PR8 virus infection, there was no significant change in the 
accumulation of 6.5+ Treg cells in the medLNs or lungs relative to isotype-treated mice, 
and the percentage expressing CXCR3 in the medLN did not significantly increase (data 
not shown).  Unfortunately, we were unable to achieve complete depletion, and some B 
cells remained, particularly in the medLN.  It is likely, given the ability of B cells to 
support Treg cell expansion and accumulation, that the remaining B cells were sufficient 
to drive expansion of 6.5+ Treg cells that remain CXCR3-, and further experiments in 
HACII.Jh-/- mice that constitutively lack B cells could explore the importance of B cells in 
6.5+ Treg cell differentiation.  Together, these observations suggest that exposure of the 
6.5+ Treg cells to the HA expressed by B cells in HACII mice before an infection was 
established could induce substantial division and accumulation of 6.5+ Treg cells without 
CXCR3 upregulation, and subsequent exposure to both the HA as a viral Ag and the 
inflammatory environment of the infection could not induce these cells to become 
CXCR3+ in PR8-infected HACII mice.  
 
These results may lead one to question how Treg cells ever come to participate 
in an anti-pathogen response, since most Treg cells are selected based on specificity for 
self-Ag.  Presentation of self-Ag by DCs appears to drive some differentiation of Treg 
cells, and this may become more apparent when cognate self-Ag is presented primarily 
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by DCs, and is not expressed and presented by B cells.  Certainly, recognition of self-HA 
in HACII mice was able to increase accumulation of 6.5+ Treg cells in the lungs during 
RV6 infection, likely due to the increased presence of MHCII+ cells (Fig. 4-6).  However, 
a relatively strong TCR signal appears to be required to induce sufficient CXCR3 
upregulation for trafficking into the lungs, since no 6.5+ Treg cells were found in the 
lungs during RV6 virus infection in HA28 mice (Fig. 4-3), and most evidence suggests 
that highly immunostimulatory self-Ags do not induce Treg cell formation, which calls into 
question the extent to which self-reactive Treg cells may be able to contribute during an 
anti-pathogen immune response.  Certainly, in our studies, TCR-mediated recognition of 
viral Ag was a much more efficient driver of Treg cell activity during infection than 
recognition of self.  Others have shown that CD4+Foxp3+ that could recognize M. 
tuberculosis-derived Ag cells, as determined by tetramer staining, expanded from Treg 
cells present in a naïve mouse, confirming that pathogen-specific Treg cells exist in the 
steady state and proliferate after encountering cognate Ag (Shafiani et al. 2013).  
Further supporting evidence for the existence of Treg cells expressing a pathogen-
reactive TCR comes from experiments in which Treg cells isolated from the site of L. 
major infection were found to expand from pre-existing Treg cells and demonstrated 
specificity for microbial Ag, as evidenced by their increased proliferation and production 
of IL-10 when cultured with infected L. major-DCs compared with uninfected DCs (Suffia 
et al. 2006).  How pathogen-reactive Treg cells come to be part of the pre-immune 
repertoire remains undetermined, but it is conceivable that some degree of homology or 
cross-reactivity exists between self and viral antigens that allows Treg cells formed on 
self-Ag to respond to pathogen-derived Ag during an infection.  In fact, both CD8+ and 
CD4+ T cells have been found to exhibit cross-reactivity that allows them to recognize 
unrelated pathogens (Su et al. 2013; Welsh et al. 2010).  Using human CD4+ T cells, it 
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was shown that clones of a CD4+ T cell selected for HIV specificity by tetramer staining 
proliferated in response to peptides derived from Micromonas and B. bifidum, but not to 
an influenza virus HA epitope (Su et al. 2013).  This phenomenon was not unique to this 
clone, as an HA-specific clone was also found to proliferate following exposure to 
peptides derived from F. magna and T. vaginalis (Su et al. 2013).  These studies provide 
a potential explanation for how Treg cells from the pre-immune repertoire and formed 
based on recognition of self-Ag could potentially recognize pathogen-derived Ag, 
differentiate, and modulate the effector immune response during an infection.  
 
5.4 Summary and conclusions 
 
 The work presented in this dissertation supports a model in which a less 
immunostimulatory form of self-Ag favors Treg cell formation both in the thymus and in 
the periphery.  However, recognition of this weakly immunostimulatory self-Ag could not 
activate Treg cells to differentiate and suppress the effector immune response during 
influenza virus infection.  In contrast, recognition of the same Ag when it was present as 
a viral Ag induced Treg cells to acquire expression of T-bet and CXCR3, to accumulate 
within the lungs, and to suppress accumulation of effector T cells.  A highly stimulatory 
form of self-Ag expressed at high levels and predominantly by APCs could drive similar 
amounts of Treg cell division as the viral Ag, but was less efficient at inducing CXCR3 
upregulation.  Furthermore, Treg cells exposed to this highly stimulatory self-Ag 
displayed an impaired ability to differentiate, accumulate in the lungs, and modulate the 
anti-viral immune response upon subsequent exposure to viral Ag.  Presentation of Ag 
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by B cells, the lack of an inflammatory environment at the time of initial TCR stimulation, 
and reduced expression of CD25, Foxp3, and the TCR may all contribute to this result.  
 
Ultimately, the studies presented here show that the immunostimulatory capacity 
of a self-Ag can be an important parameter in determining Treg cell formation and 
activity in the periphery, and demonstrate that the activity of a Treg cell in vivo cannot 
necessarily be predicted based solely on Ag specificity.  Rather, the cell type 
presentation Ag and the inflammatory environment at the time of initial antigenic 
encounter can also shape Treg cell activity.  These are important ideas to consider as 
adoptive transfer of Treg cells is introduced as a clinical therapy.  Transfer of Treg cells 
has been proposed as a therapy for autoimmune disease, solid organ transplant, and 
hematopoietic stem cell transplantation (Singer, King, D'Alessio 2014).  In some settings, 
expansion and transfer of polyclonal Treg cell populations may be sufficient to achieve 
the desired result, but, in many cases Ag-specific Treg cells have been shown to more 
efficiently suppress development of autoimmune disease than polyclonal Treg cells 
(Jaeckel, von Boehmer, Manns 2005; Masteller et al. 2005; Tang et al. 2004).  The 
recent successes with T cells expressing chimeric Ag receptors in treating acute 
lymphoblastic leukemia and chronic lymphocytic leukemia (Grupp et al. 2013; Kalos et 
al. 2011) suggest that similar protocols could be used to develop Ag-specific Treg cells 
for treatment of autoimmune disease.  However, adoptively transferred Treg cells must 
be able to differentiate appropriately in order to traffic to where they are needed and 
suppress the necessary effector cell subsets.  Clearly, a better understanding of the 
factors contributing to Treg cell formation, differentiation, and activity under different 
circumstances will be necessary to ensure the safety and efficacy of Treg cell adoptive 
therapy. 
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